JP6930847B2 - Cosmetics or topical skin agents - Google Patents
Cosmetics or topical skin agents Download PDFInfo
- Publication number
- JP6930847B2 JP6930847B2 JP2017069476A JP2017069476A JP6930847B2 JP 6930847 B2 JP6930847 B2 JP 6930847B2 JP 2017069476 A JP2017069476 A JP 2017069476A JP 2017069476 A JP2017069476 A JP 2017069476A JP 6930847 B2 JP6930847 B2 JP 6930847B2
- Authority
- JP
- Japan
- Prior art keywords
- component
- note
- discoloration
- vitamin
- extract
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Active
Links
- 239000003795 chemical substances by application Substances 0.000 title claims description 15
- 239000002537 cosmetic Substances 0.000 title description 39
- 230000000699 topical effect Effects 0.000 title 1
- GVJHHUAWPYXKBD-UHFFFAOYSA-N (±)-α-Tocopherol Chemical compound OC1=C(C)C(C)=C2OC(CCCC(C)CCCC(C)CCCC(C)C)(C)CCC2=C1C GVJHHUAWPYXKBD-UHFFFAOYSA-N 0.000 claims description 101
- 238000002845 discoloration Methods 0.000 claims description 78
- 239000000284 extract Substances 0.000 claims description 75
- 239000000203 mixture Substances 0.000 claims description 54
- 244000077995 Coix lacryma jobi Species 0.000 claims description 52
- WIGCFUFOHFEKBI-UHFFFAOYSA-N gamma-tocopherol Natural products CC(C)CCCC(C)CCCC(C)CCCC1CCC2C(C)C(O)C(C)C(C)C2O1 WIGCFUFOHFEKBI-UHFFFAOYSA-N 0.000 claims description 48
- 229930003427 Vitamin E Natural products 0.000 claims description 44
- 229940046009 vitamin E Drugs 0.000 claims description 44
- 235000019165 vitamin E Nutrition 0.000 claims description 44
- 239000011709 vitamin E Substances 0.000 claims description 44
- OYHQOLUKZRVURQ-HZJYTTRNSA-N Linoleic acid Chemical compound CCCCC\C=C/C\C=C/CCCCCCCC(O)=O OYHQOLUKZRVURQ-HZJYTTRNSA-N 0.000 claims description 29
- 235000020778 linoleic acid Nutrition 0.000 claims description 29
- OYHQOLUKZRVURQ-IXWMQOLASA-N linoleic acid Natural products CCCCC\C=C/C\C=C\CCCCCCCC(O)=O OYHQOLUKZRVURQ-IXWMQOLASA-N 0.000 claims description 27
- 235000020777 polyunsaturated fatty acids Nutrition 0.000 claims description 26
- 229940088594 vitamin Drugs 0.000 claims description 20
- 229930003231 vitamin Natural products 0.000 claims description 20
- 235000013343 vitamin Nutrition 0.000 claims description 20
- 239000011782 vitamin Substances 0.000 claims description 20
- 125000004432 carbon atom Chemical group C* 0.000 claims description 19
- 150000003722 vitamin derivatives Chemical class 0.000 claims description 17
- 241000209205 Coix Species 0.000 claims description 13
- 238000000034 method Methods 0.000 claims description 9
- 235000007354 Coix lacryma jobi Nutrition 0.000 claims description 6
- 239000004480 active ingredient Substances 0.000 claims description 5
- LFQSCWFLJHTTHZ-UHFFFAOYSA-N Ethanol Chemical compound CCO LFQSCWFLJHTTHZ-UHFFFAOYSA-N 0.000 description 67
- PUPZLCDOIYMWBV-UHFFFAOYSA-N (+/-)-1,3-Butanediol Chemical compound CC(O)CCO PUPZLCDOIYMWBV-UHFFFAOYSA-N 0.000 description 39
- 238000002360 preparation method Methods 0.000 description 36
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 description 36
- 239000004615 ingredient Substances 0.000 description 31
- 238000004519 manufacturing process Methods 0.000 description 30
- 238000000605 extraction Methods 0.000 description 25
- -1 amino acid salts Chemical class 0.000 description 24
- 239000000047 product Substances 0.000 description 22
- HEMHJVSKTPXQMS-UHFFFAOYSA-M Sodium hydroxide Chemical compound [OH-].[Na+] HEMHJVSKTPXQMS-UHFFFAOYSA-M 0.000 description 21
- 229940058015 1,3-butylene glycol Drugs 0.000 description 19
- 235000019437 butane-1,3-diol Nutrition 0.000 description 19
- PEDCQBHIVMGVHV-UHFFFAOYSA-N Glycerine Chemical compound OCC(O)CO PEDCQBHIVMGVHV-UHFFFAOYSA-N 0.000 description 16
- 239000002904 solvent Substances 0.000 description 16
- 239000006210 lotion Substances 0.000 description 15
- 230000000694 effects Effects 0.000 description 14
- 239000008213 purified water Substances 0.000 description 14
- 239000000419 plant extract Substances 0.000 description 13
- GVJHHUAWPYXKBD-IEOSBIPESA-N (R)-alpha-Tocopherol Natural products OC1=C(C)C(C)=C2O[C@@](CCC[C@H](C)CCC[C@H](C)CCCC(C)C)(C)CCC2=C1C GVJHHUAWPYXKBD-IEOSBIPESA-N 0.000 description 12
- 229920003171 Poly (ethylene oxide) Polymers 0.000 description 12
- 150000001298 alcohols Chemical class 0.000 description 12
- 238000012360 testing method Methods 0.000 description 12
- 239000003205 fragrance Substances 0.000 description 11
- 150000003839 salts Chemical class 0.000 description 11
- 239000004359 castor oil Substances 0.000 description 10
- 235000019438 castor oil Nutrition 0.000 description 10
- ZEMPKEQAKRGZGQ-XOQCFJPHSA-N glycerol triricinoleate Natural products CCCCCC[C@@H](O)CC=CCCCCCCCC(=O)OC[C@@H](COC(=O)CCCCCCCC=CC[C@@H](O)CCCCCC)OC(=O)CCCCCCCC=CC[C@H](O)CCCCCC ZEMPKEQAKRGZGQ-XOQCFJPHSA-N 0.000 description 10
- GZIFEOYASATJEH-VHFRWLAGSA-N δ-tocopherol Chemical compound OC1=CC(C)=C2O[C@@](CCC[C@H](C)CCC[C@H](C)CCCC(C)C)(C)CCC2=C1 GZIFEOYASATJEH-VHFRWLAGSA-N 0.000 description 10
- 235000021588 free fatty acids Nutrition 0.000 description 9
- 229960000984 tocofersolan Drugs 0.000 description 9
- AOBORMOPSGHCAX-DGHZZKTQSA-N tocofersolan Chemical compound OCCOC(=O)CCC(=O)OC1=C(C)C(C)=C2O[C@](CCC[C@H](C)CCC[C@H](C)CCCC(C)C)(C)CCC2=C1C AOBORMOPSGHCAX-DGHZZKTQSA-N 0.000 description 9
- 241000209504 Poaceae Species 0.000 description 8
- 239000003814 drug Substances 0.000 description 8
- 235000011187 glycerol Nutrition 0.000 description 8
- 239000007788 liquid Substances 0.000 description 8
- WWZKQHOCKIZLMA-UHFFFAOYSA-N octanoic acid Chemical compound CCCCCCCC(O)=O WWZKQHOCKIZLMA-UHFFFAOYSA-N 0.000 description 8
- 235000001815 DL-alpha-tocopherol Nutrition 0.000 description 7
- 239000011627 DL-alpha-tocopherol Substances 0.000 description 7
- 241000196324 Embryophyta Species 0.000 description 7
- 241000736199 Paeonia Species 0.000 description 7
- 239000007864 aqueous solution Substances 0.000 description 7
- 230000003796 beauty Effects 0.000 description 7
- 125000002496 methyl group Chemical group [H]C([H])([H])* 0.000 description 7
- 229930003799 tocopherol Natural products 0.000 description 7
- 239000011732 tocopherol Substances 0.000 description 7
- 230000002087 whitening effect Effects 0.000 description 7
- 239000002076 α-tocopherol Substances 0.000 description 7
- 235000004835 α-tocopherol Nutrition 0.000 description 7
- OKKJLVBELUTLKV-UHFFFAOYSA-N Methanol Chemical compound OC OKKJLVBELUTLKV-UHFFFAOYSA-N 0.000 description 6
- 235000006484 Paeonia officinalis Nutrition 0.000 description 6
- NBIIXXVUZAFLBC-UHFFFAOYSA-N Phosphoric acid Chemical compound OP(O)(O)=O NBIIXXVUZAFLBC-UHFFFAOYSA-N 0.000 description 6
- DNIAPMSPPWPWGF-UHFFFAOYSA-N Propylene glycol Chemical compound CC(O)CO DNIAPMSPPWPWGF-UHFFFAOYSA-N 0.000 description 6
- 229920002125 Sokalan® Polymers 0.000 description 6
- 229940087168 alpha tocopherol Drugs 0.000 description 6
- DTOSIQBPPRVQHS-PDBXOOCHSA-N alpha-linolenic acid Chemical compound CC\C=C/C\C=C/C\C=C/CCCCCCCC(O)=O DTOSIQBPPRVQHS-PDBXOOCHSA-N 0.000 description 6
- 235000010389 delta-tocopherol Nutrition 0.000 description 6
- 239000003974 emollient agent Substances 0.000 description 6
- 235000013305 food Nutrition 0.000 description 6
- 239000003112 inhibitor Substances 0.000 description 6
- 229940092258 rosemary extract Drugs 0.000 description 6
- 235000020748 rosemary extract Nutrition 0.000 description 6
- 239000001233 rosmarinus officinalis l. extract Substances 0.000 description 6
- 239000000243 solution Substances 0.000 description 6
- 235000010384 tocopherol Nutrition 0.000 description 6
- 229960001295 tocopherol Drugs 0.000 description 6
- WGVKWNUPNGFDFJ-DQCZWYHMSA-N β-tocopherol Chemical compound OC1=CC(C)=C2O[C@@](CCC[C@H](C)CCC[C@H](C)CCCC(C)C)(C)CCC2=C1C WGVKWNUPNGFDFJ-DQCZWYHMSA-N 0.000 description 6
- GZIFEOYASATJEH-UHFFFAOYSA-N D-delta tocopherol Natural products OC1=CC(C)=C2OC(CCCC(C)CCCC(C)CCCC(C)C)(C)CCC2=C1 GZIFEOYASATJEH-UHFFFAOYSA-N 0.000 description 5
- 230000000052 comparative effect Effects 0.000 description 5
- 239000000839 emulsion Substances 0.000 description 5
- 150000002148 esters Chemical class 0.000 description 5
- 239000011521 glass Substances 0.000 description 5
- 229940094952 green tea extract Drugs 0.000 description 5
- 235000020688 green tea extract Nutrition 0.000 description 5
- 239000007764 o/w emulsion Substances 0.000 description 5
- 239000011734 sodium Substances 0.000 description 5
- 238000003756 stirring Methods 0.000 description 5
- 239000000126 substance Substances 0.000 description 5
- 235000015112 vegetable and seed oil Nutrition 0.000 description 5
- 239000008158 vegetable oil Substances 0.000 description 5
- 239000000230 xanthan gum Substances 0.000 description 5
- 229920001285 xanthan gum Polymers 0.000 description 5
- 235000010493 xanthan gum Nutrition 0.000 description 5
- 229940082509 xanthan gum Drugs 0.000 description 5
- 239000002446 δ-tocopherol Substances 0.000 description 5
- XDOFQFKRPWOURC-UHFFFAOYSA-N 16-methylheptadecanoic acid Chemical compound CC(C)CCCCCCCCCCCCCCC(O)=O XDOFQFKRPWOURC-UHFFFAOYSA-N 0.000 description 4
- 239000005635 Caprylic acid (CAS 124-07-2) Substances 0.000 description 4
- LYCAIKOWRPUZTN-UHFFFAOYSA-N Ethylene glycol Chemical compound OCCO LYCAIKOWRPUZTN-UHFFFAOYSA-N 0.000 description 4
- 230000003078 antioxidant effect Effects 0.000 description 4
- 229920001577 copolymer Polymers 0.000 description 4
- 239000006071 cream Substances 0.000 description 4
- 239000004205 dimethyl polysiloxane Substances 0.000 description 4
- 235000013870 dimethyl polysiloxane Nutrition 0.000 description 4
- 229940079593 drug Drugs 0.000 description 4
- 238000001914 filtration Methods 0.000 description 4
- 235000010382 gamma-tocopherol Nutrition 0.000 description 4
- 238000010438 heat treatment Methods 0.000 description 4
- JVTAAEKCZFNVCJ-UHFFFAOYSA-N lactic acid Chemical compound CC(O)C(O)=O JVTAAEKCZFNVCJ-UHFFFAOYSA-N 0.000 description 4
- GLDOVTGHNKAZLK-UHFFFAOYSA-N octadecan-1-ol Chemical compound CCCCCCCCCCCCCCCCCCO GLDOVTGHNKAZLK-UHFFFAOYSA-N 0.000 description 4
- 229960002446 octanoic acid Drugs 0.000 description 4
- 229920000435 poly(dimethylsiloxane) Polymers 0.000 description 4
- 230000000475 sunscreen effect Effects 0.000 description 4
- 239000000516 sunscreening agent Substances 0.000 description 4
- 239000009538 yokuinin Substances 0.000 description 4
- 239000002478 γ-tocopherol Substances 0.000 description 4
- QUEDXNHFTDJVIY-DQCZWYHMSA-N γ-tocopherol Chemical compound OC1=C(C)C(C)=C2O[C@@](CCC[C@H](C)CCC[C@H](C)CCCC(C)C)(C)CCC2=C1 QUEDXNHFTDJVIY-DQCZWYHMSA-N 0.000 description 4
- DVSZKTAMJJTWFG-SKCDLICFSA-N (2e,4e,6e,8e,10e,12e)-docosa-2,4,6,8,10,12-hexaenoic acid Chemical compound CCCCCCCCC\C=C\C=C\C=C\C=C\C=C\C=C\C(O)=O DVSZKTAMJJTWFG-SKCDLICFSA-N 0.000 description 3
- XHZPRMZZQOIPDS-UHFFFAOYSA-N 2-Methyl-2-[(1-oxo-2-propenyl)amino]-1-propanesulfonic acid Chemical compound OS(=O)(=O)CC(C)(C)NC(=O)C=C XHZPRMZZQOIPDS-UHFFFAOYSA-N 0.000 description 3
- GZJLLYHBALOKEX-UHFFFAOYSA-N 6-Ketone, O18-Me-Ussuriedine Natural products CC=CCC=CCC=CCC=CCC=CCC=CCCCC(O)=O GZJLLYHBALOKEX-UHFFFAOYSA-N 0.000 description 3
- QTBSBXVTEAMEQO-UHFFFAOYSA-N Acetic acid Chemical compound CC(O)=O QTBSBXVTEAMEQO-UHFFFAOYSA-N 0.000 description 3
- CSCPPACGZOOCGX-UHFFFAOYSA-N Acetone Chemical compound CC(C)=O CSCPPACGZOOCGX-UHFFFAOYSA-N 0.000 description 3
- UHOVQNZJYSORNB-UHFFFAOYSA-N Benzene Chemical compound C1=CC=CC=C1 UHOVQNZJYSORNB-UHFFFAOYSA-N 0.000 description 3
- 241000195493 Cryptophyta Species 0.000 description 3
- ZAKOWWREFLAJOT-CEFNRUSXSA-N D-alpha-tocopherylacetate Chemical compound CC(=O)OC1=C(C)C(C)=C2O[C@@](CCC[C@H](C)CCC[C@H](C)CCCC(C)C)(C)CCC2=C1C ZAKOWWREFLAJOT-CEFNRUSXSA-N 0.000 description 3
- XEKOWRVHYACXOJ-UHFFFAOYSA-N Ethyl acetate Chemical compound CCOC(C)=O XEKOWRVHYACXOJ-UHFFFAOYSA-N 0.000 description 3
- JAZBEHYOTPTENJ-JLNKQSITSA-N all-cis-5,8,11,14,17-icosapentaenoic acid Chemical compound CC\C=C/C\C=C/C\C=C/C\C=C/C\C=C/CCCC(O)=O JAZBEHYOTPTENJ-JLNKQSITSA-N 0.000 description 3
- 235000020661 alpha-linolenic acid Nutrition 0.000 description 3
- 229910000147 aluminium phosphate Inorganic materials 0.000 description 3
- 229940066595 beta tocopherol Drugs 0.000 description 3
- KRKNYBCHXYNGOX-UHFFFAOYSA-N citric acid Chemical compound OC(=O)CC(O)(C(O)=O)CC(O)=O KRKNYBCHXYNGOX-UHFFFAOYSA-N 0.000 description 3
- 229920006037 cross link polymer Polymers 0.000 description 3
- 229940008099 dimethicone Drugs 0.000 description 3
- SZXQTJUDPRGNJN-UHFFFAOYSA-N dipropylene glycol Chemical compound OCCCOCCCO SZXQTJUDPRGNJN-UHFFFAOYSA-N 0.000 description 3
- 235000020669 docosahexaenoic acid Nutrition 0.000 description 3
- KAUVQQXNCKESLC-UHFFFAOYSA-N docosahexaenoic acid (DHA) Natural products COC(=O)C(C)NOCC1=CC=CC=C1 KAUVQQXNCKESLC-UHFFFAOYSA-N 0.000 description 3
- 238000001035 drying Methods 0.000 description 3
- 235000020673 eicosapentaenoic acid Nutrition 0.000 description 3
- 229960005135 eicosapentaenoic acid Drugs 0.000 description 3
- JAZBEHYOTPTENJ-UHFFFAOYSA-N eicosapentaenoic acid Natural products CCC=CCC=CCC=CCC=CCC=CCCCC(O)=O JAZBEHYOTPTENJ-UHFFFAOYSA-N 0.000 description 3
- 238000004945 emulsification Methods 0.000 description 3
- 238000011156 evaluation Methods 0.000 description 3
- 239000000706 filtrate Substances 0.000 description 3
- 239000008269 hand cream Substances 0.000 description 3
- 230000001771 impaired effect Effects 0.000 description 3
- 229960004488 linolenic acid Drugs 0.000 description 3
- 238000005259 measurement Methods 0.000 description 3
- 238000002156 mixing Methods 0.000 description 3
- VLKZOEOYAKHREP-UHFFFAOYSA-N n-Hexane Chemical compound CCCCCC VLKZOEOYAKHREP-UHFFFAOYSA-N 0.000 description 3
- WCVRQHFDJLLWFE-UHFFFAOYSA-N pentane-1,2-diol Chemical compound CCCC(O)CO WCVRQHFDJLLWFE-UHFFFAOYSA-N 0.000 description 3
- 229940042585 tocopherol acetate Drugs 0.000 description 3
- 235000007680 β-tocopherol Nutrition 0.000 description 3
- 239000011590 β-tocopherol Substances 0.000 description 3
- JNYAEWCLZODPBN-JGWLITMVSA-N (2r,3r,4s)-2-[(1r)-1,2-dihydroxyethyl]oxolane-3,4-diol Chemical compound OC[C@@H](O)[C@H]1OC[C@H](O)[C@H]1O JNYAEWCLZODPBN-JGWLITMVSA-N 0.000 description 2
- YYGNTYWPHWGJRM-UHFFFAOYSA-N (6E,10E,14E,18E)-2,6,10,15,19,23-hexamethyltetracosa-2,6,10,14,18,22-hexaene Chemical compound CC(C)=CCCC(C)=CCCC(C)=CCCC=C(C)CCC=C(C)CCC=C(C)C YYGNTYWPHWGJRM-UHFFFAOYSA-N 0.000 description 2
- OYHQOLUKZRVURQ-NTGFUMLPSA-N (9Z,12Z)-9,10,12,13-tetratritiooctadeca-9,12-dienoic acid Chemical compound C(CCCCCCC\C(=C(/C\C(=C(/CCCCC)\[3H])\[3H])\[3H])\[3H])(=O)O OYHQOLUKZRVURQ-NTGFUMLPSA-N 0.000 description 2
- PQUXFUBNSYCQAL-UHFFFAOYSA-N 1-(2,3-difluorophenyl)ethanone Chemical compound CC(=O)C1=CC=CC(F)=C1F PQUXFUBNSYCQAL-UHFFFAOYSA-N 0.000 description 2
- QCDWFXQBSFUVSP-UHFFFAOYSA-N 2-phenoxyethanol Chemical compound OCCOC1=CC=CC=C1 QCDWFXQBSFUVSP-UHFFFAOYSA-N 0.000 description 2
- CYDQOEWLBCCFJZ-UHFFFAOYSA-N 4-(4-fluorophenyl)oxane-4-carboxylic acid Chemical compound C=1C=C(F)C=CC=1C1(C(=O)O)CCOCC1 CYDQOEWLBCCFJZ-UHFFFAOYSA-N 0.000 description 2
- NIXOWILDQLNWCW-UHFFFAOYSA-M Acrylate Chemical compound [O-]C(=O)C=C NIXOWILDQLNWCW-UHFFFAOYSA-M 0.000 description 2
- 241000209507 Camellia Species 0.000 description 2
- CURLTUGMZLYLDI-UHFFFAOYSA-N Carbon dioxide Chemical compound O=C=O CURLTUGMZLYLDI-UHFFFAOYSA-N 0.000 description 2
- RTZKZFJDLAIYFH-UHFFFAOYSA-N Diethyl ether Chemical compound CCOCC RTZKZFJDLAIYFH-UHFFFAOYSA-N 0.000 description 2
- ZGTMUACCHSMWAC-UHFFFAOYSA-L EDTA disodium salt (anhydrous) Chemical compound [Na+].[Na+].OC(=O)CN(CC([O-])=O)CCN(CC(O)=O)CC([O-])=O ZGTMUACCHSMWAC-UHFFFAOYSA-L 0.000 description 2
- UQSXHKLRYXJYBZ-UHFFFAOYSA-N Iron oxide Chemical compound [Fe]=O UQSXHKLRYXJYBZ-UHFFFAOYSA-N 0.000 description 2
- 235000018330 Macadamia integrifolia Nutrition 0.000 description 2
- 240000000912 Macadamia tetraphylla Species 0.000 description 2
- 235000003800 Macadamia tetraphylla Nutrition 0.000 description 2
- IEZRNEGTKRQRFV-LFBNJJMOSA-N N-octadecanoyl-4-hydroxysphinganine Chemical compound CCCCCCCCCCCCCCCCCC(=O)N[C@@H](CO)[C@H](O)[C@H](O)CCCCCCCCCCCCCC IEZRNEGTKRQRFV-LFBNJJMOSA-N 0.000 description 2
- ATGQXSBKTQANOH-UWVGARPKSA-N N-oleoylphytosphingosine Chemical compound CCCCCCCCCCCCCC[C@@H](O)[C@@H](O)[C@H](CO)NC(=O)CCCCCCC\C=C/CCCCCCCC ATGQXSBKTQANOH-UWVGARPKSA-N 0.000 description 2
- 229910019142 PO4 Inorganic materials 0.000 description 2
- 239000002202 Polyethylene glycol Substances 0.000 description 2
- VYGQUTWHTHXGQB-FFHKNEKCSA-N Retinol Palmitate Chemical compound CCCCCCCCCCCCCCCC(=O)OC\C=C(/C)\C=C\C=C(/C)\C=C\C1=C(C)CCCC1(C)C VYGQUTWHTHXGQB-FFHKNEKCSA-N 0.000 description 2
- 229920002385 Sodium hyaluronate Polymers 0.000 description 2
- BHEOSNUKNHRBNM-UHFFFAOYSA-N Tetramethylsqualene Natural products CC(=C)C(C)CCC(=C)C(C)CCC(C)=CCCC=C(C)CCC(C)C(=C)CCC(C)C(C)=C BHEOSNUKNHRBNM-UHFFFAOYSA-N 0.000 description 2
- 244000269722 Thea sinensis Species 0.000 description 2
- GSEJCLTVZPLZKY-UHFFFAOYSA-N Triethanolamine Chemical class OCCN(CCO)CCO GSEJCLTVZPLZKY-UHFFFAOYSA-N 0.000 description 2
- XLOMVQKBTHCTTD-UHFFFAOYSA-N Zinc monoxide Chemical compound [Zn]=O XLOMVQKBTHCTTD-UHFFFAOYSA-N 0.000 description 2
- 229940048053 acrylate Drugs 0.000 description 2
- 150000005215 alkyl ethers Chemical class 0.000 description 2
- YZXBAPSDXZZRGB-DOFZRALJSA-N arachidonic acid Chemical compound CCCCC\C=C/C\C=C/C\C=C/C\C=C/CCCC(O)=O YZXBAPSDXZZRGB-DOFZRALJSA-N 0.000 description 2
- 229960005070 ascorbic acid Drugs 0.000 description 2
- 230000017531 blood circulation Effects 0.000 description 2
- 229940044176 ceramide 3 Drugs 0.000 description 2
- 235000018597 common camellia Nutrition 0.000 description 2
- 239000002781 deodorant agent Substances 0.000 description 2
- 235000014113 dietary fatty acids Nutrition 0.000 description 2
- BNIILDVGGAEEIG-UHFFFAOYSA-L disodium hydrogen phosphate Chemical compound [Na+].[Na+].OP([O-])([O-])=O BNIILDVGGAEEIG-UHFFFAOYSA-L 0.000 description 2
- NOPFSRXAKWQILS-UHFFFAOYSA-N docosan-1-ol Chemical compound CCCCCCCCCCCCCCCCCCCCCCO NOPFSRXAKWQILS-UHFFFAOYSA-N 0.000 description 2
- PRAKJMSDJKAYCZ-UHFFFAOYSA-N dodecahydrosqualene Natural products CC(C)CCCC(C)CCCC(C)CCCCC(C)CCCC(C)CCCC(C)C PRAKJMSDJKAYCZ-UHFFFAOYSA-N 0.000 description 2
- 229930195729 fatty acid Natural products 0.000 description 2
- 239000000194 fatty acid Substances 0.000 description 2
- 150000004665 fatty acids Chemical class 0.000 description 2
- 230000002431 foraging effect Effects 0.000 description 2
- 229960002989 glutamic acid Drugs 0.000 description 2
- 125000003976 glyceryl group Chemical group [H]C([*])([H])C(O[H])([H])C(O[H])([H])[H] 0.000 description 2
- 229920000578 graft copolymer Polymers 0.000 description 2
- WGCNASOHLSPBMP-UHFFFAOYSA-N hydroxyacetaldehyde Natural products OCC=O WGCNASOHLSPBMP-UHFFFAOYSA-N 0.000 description 2
- 239000012535 impurity Substances 0.000 description 2
- 239000004310 lactic acid Substances 0.000 description 2
- 235000014655 lactic acid Nutrition 0.000 description 2
- 229940057995 liquid paraffin Drugs 0.000 description 2
- 229910052751 metal Inorganic materials 0.000 description 2
- 239000002184 metal Substances 0.000 description 2
- 244000005700 microbiome Species 0.000 description 2
- 239000011259 mixed solution Substances 0.000 description 2
- GOQYKNQRPGWPLP-UHFFFAOYSA-N n-heptadecyl alcohol Natural products CCCCCCCCCCCCCCCCCO GOQYKNQRPGWPLP-UHFFFAOYSA-N 0.000 description 2
- 239000010466 nut oil Substances 0.000 description 2
- 239000003921 oil Substances 0.000 description 2
- 235000019198 oils Nutrition 0.000 description 2
- 239000003960 organic solvent Substances 0.000 description 2
- 229960005323 phenoxyethanol Drugs 0.000 description 2
- 239000010452 phosphate Substances 0.000 description 2
- 229920001223 polyethylene glycol Polymers 0.000 description 2
- 229920001296 polysiloxane Polymers 0.000 description 2
- 230000001737 promoting effect Effects 0.000 description 2
- 238000000746 purification Methods 0.000 description 2
- 238000000926 separation method Methods 0.000 description 2
- 229940047670 sodium acrylate Drugs 0.000 description 2
- 229940010747 sodium hyaluronate Drugs 0.000 description 2
- 239000001540 sodium lactate Substances 0.000 description 2
- 229940005581 sodium lactate Drugs 0.000 description 2
- 235000011088 sodium lactate Nutrition 0.000 description 2
- YWIVKILSMZOHHF-QJZPQSOGSA-N sodium;(2s,3s,4s,5r,6r)-6-[(2s,3r,4r,5s,6r)-3-acetamido-2-[(2s,3s,4r,5r,6r)-6-[(2r,3r,4r,5s,6r)-3-acetamido-2,5-dihydroxy-6-(hydroxymethyl)oxan-4-yl]oxy-2-carboxy-4,5-dihydroxyoxan-3-yl]oxy-5-hydroxy-6-(hydroxymethyl)oxan-4-yl]oxy-3,4,5-trihydroxyoxane-2- Chemical compound [Na+].CC(=O)N[C@H]1[C@H](O)O[C@H](CO)[C@@H](O)[C@@H]1O[C@H]1[C@H](O)[C@@H](O)[C@H](O[C@H]2[C@@H]([C@@H](O[C@H]3[C@@H]([C@@H](O)[C@H](O)[C@H](O3)C(O)=O)O)[C@H](O)[C@@H](CO)O2)NC(C)=O)[C@@H](C(O)=O)O1 YWIVKILSMZOHHF-QJZPQSOGSA-N 0.000 description 2
- 239000007787 solid Substances 0.000 description 2
- 229940031439 squalene Drugs 0.000 description 2
- TUHBEKDERLKLEC-UHFFFAOYSA-N squalene Natural products CC(=CCCC(=CCCC(=CCCC=C(/C)CCC=C(/C)CC=C(C)C)C)C)C TUHBEKDERLKLEC-UHFFFAOYSA-N 0.000 description 2
- 229940099259 vaseline Drugs 0.000 description 2
- 150000003712 vitamin E derivatives Chemical class 0.000 description 2
- HDTRYLNUVZCQOY-UHFFFAOYSA-N α-D-glucopyranosyl-α-D-glucopyranoside Natural products OC1C(O)C(O)C(CO)OC1OC1C(O)C(O)C(O)C(CO)O1 HDTRYLNUVZCQOY-UHFFFAOYSA-N 0.000 description 1
- CUNWUEBNSZSNRX-RKGWDQTMSA-N (2r,3r,4r,5s)-hexane-1,2,3,4,5,6-hexol;(z)-octadec-9-enoic acid Chemical compound OC[C@H](O)[C@@H](O)[C@H](O)[C@H](O)CO.OC[C@H](O)[C@@H](O)[C@H](O)[C@H](O)CO.CCCCCCCC\C=C/CCCCCCCC(O)=O.CCCCCCCC\C=C/CCCCCCCC(O)=O.CCCCCCCC\C=C/CCCCCCCC(O)=O CUNWUEBNSZSNRX-RKGWDQTMSA-N 0.000 description 1
- KZRXPHCVIMWWDS-AWEZNQCLSA-N (4S)-4-amino-5-dodecanoyloxy-5-oxopentanoic acid Chemical compound CCCCCCCCCCCC(=O)OC(=O)[C@@H](N)CCC(O)=O KZRXPHCVIMWWDS-AWEZNQCLSA-N 0.000 description 1
- HOBAELRKJCKHQD-UHFFFAOYSA-N (8Z,11Z,14Z)-8,11,14-eicosatrienoic acid Natural products CCCCCC=CCC=CCC=CCCCCCCC(O)=O HOBAELRKJCKHQD-UHFFFAOYSA-N 0.000 description 1
- NWUYHJFMYQTDRP-UHFFFAOYSA-N 1,2-bis(ethenyl)benzene;1-ethenyl-2-ethylbenzene;styrene Chemical compound C=CC1=CC=CC=C1.CCC1=CC=CC=C1C=C.C=CC1=CC=CC=C1C=C NWUYHJFMYQTDRP-UHFFFAOYSA-N 0.000 description 1
- JLPULHDHAOZNQI-ZTIMHPMXSA-N 1-hexadecanoyl-2-(9Z,12Z-octadecadienoyl)-sn-glycero-3-phosphocholine Chemical class CCCCCCCCCCCCCCCC(=O)OC[C@H](COP([O-])(=O)OCC[N+](C)(C)C)OC(=O)CCCCCCC\C=C/C\C=C/CCCCC JLPULHDHAOZNQI-ZTIMHPMXSA-N 0.000 description 1
- VBICKXHEKHSIBG-UHFFFAOYSA-N 1-monostearoylglycerol Chemical compound CCCCCCCCCCCCCCCCCC(=O)OCC(O)CO VBICKXHEKHSIBG-UHFFFAOYSA-N 0.000 description 1
- WAYINTBTZWQNSN-UHFFFAOYSA-N 11-methyldodecyl 3,5,5-trimethylhexanoate Chemical compound CC(C)CCCCCCCCCCOC(=O)CC(C)CC(C)(C)C WAYINTBTZWQNSN-UHFFFAOYSA-N 0.000 description 1
- DGSZGZSCHSQXFV-UHFFFAOYSA-N 2,3-bis(2-ethylhexanoyloxy)propyl 2-ethylhexanoate Chemical compound CCCCC(CC)C(=O)OCC(OC(=O)C(CC)CCCC)COC(=O)C(CC)CCCC DGSZGZSCHSQXFV-UHFFFAOYSA-N 0.000 description 1
- SMZOUWXMTYCWNB-UHFFFAOYSA-N 2-(2-methoxy-5-methylphenyl)ethanamine Chemical compound COC1=CC=C(C)C=C1CCN SMZOUWXMTYCWNB-UHFFFAOYSA-N 0.000 description 1
- NIXOWILDQLNWCW-UHFFFAOYSA-N 2-Propenoic acid Natural products OC(=O)C=C NIXOWILDQLNWCW-UHFFFAOYSA-N 0.000 description 1
- TWJNQYPJQDRXPH-UHFFFAOYSA-N 2-cyanobenzohydrazide Chemical compound NNC(=O)C1=CC=CC=C1C#N TWJNQYPJQDRXPH-UHFFFAOYSA-N 0.000 description 1
- NFIHXTUNNGIYRF-UHFFFAOYSA-N 2-decanoyloxypropyl decanoate Chemical compound CCCCCCCCCC(=O)OCC(C)OC(=O)CCCCCCCCC NFIHXTUNNGIYRF-UHFFFAOYSA-N 0.000 description 1
- RFVNOJDQRGSOEL-UHFFFAOYSA-N 2-hydroxyethyl octadecanoate Chemical compound CCCCCCCCCCCCCCCCCC(=O)OCCO RFVNOJDQRGSOEL-UHFFFAOYSA-N 0.000 description 1
- SNZLFTJKILZFKF-UHFFFAOYSA-N 2-methoxy-3-phenylundec-2-enoic acid Chemical compound CCCCCCCCC(=C(OC)C(O)=O)C1=CC=CC=C1 SNZLFTJKILZFKF-UHFFFAOYSA-N 0.000 description 1
- GJJVAFUKOBZPCB-UHFFFAOYSA-N 2-methyl-2-(4,8,12-trimethyltrideca-3,7,11-trienyl)-3,4-dihydrochromen-6-ol Chemical compound OC1=CC=C2OC(CCC=C(C)CCC=C(C)CCC=C(C)C)(C)CCC2=C1 GJJVAFUKOBZPCB-UHFFFAOYSA-N 0.000 description 1
- ODADKLYLWWCHNB-UHFFFAOYSA-N 2R-delta-tocotrienol Natural products OC1=CC(C)=C2OC(CCC=C(C)CCC=C(C)CCC=C(C)C)(C)CCC2=C1 ODADKLYLWWCHNB-UHFFFAOYSA-N 0.000 description 1
- OTXNTMVVOOBZCV-UHFFFAOYSA-N 2R-gamma-tocotrienol Natural products OC1=C(C)C(C)=C2OC(CCC=C(C)CCC=C(C)CCC=C(C)C)(C)CCC2=C1 OTXNTMVVOOBZCV-UHFFFAOYSA-N 0.000 description 1
- HVYWMOMLDIMFJA-UHFFFAOYSA-N 3-cholesterol Natural products C1C=C2CC(O)CCC2(C)C2C1C1CCC(C(C)CCCC(C)C)C1(C)CC2 HVYWMOMLDIMFJA-UHFFFAOYSA-N 0.000 description 1
- QTBSBXVTEAMEQO-UHFFFAOYSA-M Acetate Chemical compound CC([O-])=O QTBSBXVTEAMEQO-UHFFFAOYSA-M 0.000 description 1
- 241000256844 Apis mellifera Species 0.000 description 1
- 240000002900 Arthrospira platensis Species 0.000 description 1
- 235000016425 Arthrospira platensis Nutrition 0.000 description 1
- CIWBSHSKHKDKBQ-JLAZNSOCSA-N Ascorbic acid Natural products OC[C@H](O)[C@H]1OC(=O)C(O)=C1O CIWBSHSKHKDKBQ-JLAZNSOCSA-N 0.000 description 1
- 240000002791 Brassica napus Species 0.000 description 1
- 235000004977 Brassica sinapistrum Nutrition 0.000 description 1
- SGPMPZKXUXPIBJ-UHFFFAOYSA-N C(C)C(CCCCC(=O)OCC(O)CO)(CC)CC Chemical compound C(C)C(CCCCC(=O)OCC(O)CO)(CC)CC SGPMPZKXUXPIBJ-UHFFFAOYSA-N 0.000 description 1
- OKTJSMMVPCPJKN-UHFFFAOYSA-N Carbon Chemical compound [C] OKTJSMMVPCPJKN-UHFFFAOYSA-N 0.000 description 1
- 229920002134 Carboxymethyl cellulose Polymers 0.000 description 1
- 241000195649 Chlorella <Chlorellales> Species 0.000 description 1
- ACTIUHUUMQJHFO-UHFFFAOYSA-N Coenzym Q10 Natural products COC1=C(OC)C(=O)C(CC=C(C)CCC=C(C)CCC=C(C)CCC=C(C)CCC=C(C)CCC=C(C)CCC=C(C)CCC=C(C)CCC=C(C)CCC=C(C)C)=C(C)C1=O ACTIUHUUMQJHFO-UHFFFAOYSA-N 0.000 description 1
- 235000014282 Coix lacryma jobi var ma yuen Nutrition 0.000 description 1
- 240000008143 Coix lacryma-jobi var. ma-yuen Species 0.000 description 1
- 102000008186 Collagen Human genes 0.000 description 1
- 108010035532 Collagen Proteins 0.000 description 1
- FBPFZTCFMRRESA-FSIIMWSLSA-N D-Glucitol Natural products OC[C@H](O)[C@H](O)[C@@H](O)[C@H](O)CO FBPFZTCFMRRESA-FSIIMWSLSA-N 0.000 description 1
- XMSXQFUHVRWGNA-UHFFFAOYSA-N Decamethylcyclopentasiloxane Chemical compound C[Si]1(C)O[Si](C)(C)O[Si](C)(C)O[Si](C)(C)O[Si](C)(C)O1 XMSXQFUHVRWGNA-UHFFFAOYSA-N 0.000 description 1
- 235000021298 Dihomo-γ-linolenic acid Nutrition 0.000 description 1
- 102000016942 Elastin Human genes 0.000 description 1
- 108010014258 Elastin Proteins 0.000 description 1
- 102000004190 Enzymes Human genes 0.000 description 1
- 108090000790 Enzymes Proteins 0.000 description 1
- 206010014970 Ephelides Diseases 0.000 description 1
- 241000195620 Euglena Species 0.000 description 1
- 244000068988 Glycine max Species 0.000 description 1
- 235000010469 Glycine max Nutrition 0.000 description 1
- 240000004670 Glycyrrhiza echinata Species 0.000 description 1
- 235000001453 Glycyrrhiza echinata Nutrition 0.000 description 1
- 235000006200 Glycyrrhiza glabra Nutrition 0.000 description 1
- 235000017382 Glycyrrhiza lepidota Nutrition 0.000 description 1
- PMMYEEVYMWASQN-DMTCNVIQSA-N Hydroxyproline Chemical compound O[C@H]1CN[C@H](C(O)=O)C1 PMMYEEVYMWASQN-DMTCNVIQSA-N 0.000 description 1
- 239000002211 L-ascorbic acid Substances 0.000 description 1
- KDXKERNSBIXSRK-YFKPBYRVSA-N L-lysine Chemical class NCCCC[C@H](N)C(O)=O KDXKERNSBIXSRK-YFKPBYRVSA-N 0.000 description 1
- 241000207923 Lamiaceae Species 0.000 description 1
- FYYHWMGAXLPEAU-UHFFFAOYSA-N Magnesium Chemical compound [Mg] FYYHWMGAXLPEAU-UHFFFAOYSA-N 0.000 description 1
- 208000003351 Melanosis Diseases 0.000 description 1
- 241001465754 Metazoa Species 0.000 description 1
- RGMZNZABJYWAEC-UHFFFAOYSA-N Methyltris(trimethylsiloxy)silane Chemical compound C[Si](C)(C)O[Si](C)(O[Si](C)(C)C)O[Si](C)(C)C RGMZNZABJYWAEC-UHFFFAOYSA-N 0.000 description 1
- 239000004909 Moisturizer Substances 0.000 description 1
- 235000021360 Myristic acid Nutrition 0.000 description 1
- TUNFSRHWOTWDNC-UHFFFAOYSA-N Myristic acid Natural products CCCCCCCCCCCCCC(O)=O TUNFSRHWOTWDNC-UHFFFAOYSA-N 0.000 description 1
- 229940123973 Oxygen scavenger Drugs 0.000 description 1
- 244000236658 Paeonia lactiflora Species 0.000 description 1
- 235000008598 Paeonia lactiflora Nutrition 0.000 description 1
- 241001106477 Paeoniaceae Species 0.000 description 1
- 208000012641 Pigmentation disease Diseases 0.000 description 1
- 229920002565 Polyethylene Glycol 400 Polymers 0.000 description 1
- 241001529742 Rosmarinus Species 0.000 description 1
- 244000178231 Rosmarinus officinalis Species 0.000 description 1
- KDYFGRWQOYBRFD-UHFFFAOYSA-N Succinic acid Natural products OC(=O)CCC(O)=O KDYFGRWQOYBRFD-UHFFFAOYSA-N 0.000 description 1
- 235000006468 Thea sinensis Nutrition 0.000 description 1
- GWEVSGVZZGPLCZ-UHFFFAOYSA-N Titan oxide Chemical compound O=[Ti]=O GWEVSGVZZGPLCZ-UHFFFAOYSA-N 0.000 description 1
- MSCCTZZBYHQMQJ-AZAGJHQNSA-N Tocopheryl nicotinate Chemical compound C([C@@](OC1=C(C)C=2C)(C)CCC[C@H](C)CCC[C@H](C)CCCC(C)C)CC1=C(C)C=2OC(=O)C1=CC=CN=C1 MSCCTZZBYHQMQJ-AZAGJHQNSA-N 0.000 description 1
- HDTRYLNUVZCQOY-WSWWMNSNSA-N Trehalose Natural products O[C@@H]1[C@@H](O)[C@@H](O)[C@@H](CO)O[C@@H]1O[C@@H]1[C@H](O)[C@@H](O)[C@@H](O)[C@@H](CO)O1 HDTRYLNUVZCQOY-WSWWMNSNSA-N 0.000 description 1
- 235000021307 Triticum Nutrition 0.000 description 1
- 244000098338 Triticum aestivum Species 0.000 description 1
- KGLAXXUXWSFQMO-UHFFFAOYSA-N [Na].C(C=C)(=O)C(N(C)C)CS(=O)(=O)O Chemical compound [Na].C(C=C)(=O)C(N(C)C)CS(=O)(=O)O KGLAXXUXWSFQMO-UHFFFAOYSA-N 0.000 description 1
- 239000012190 activator Substances 0.000 description 1
- 239000000443 aerosol Substances 0.000 description 1
- 230000032683 aging Effects 0.000 description 1
- 125000005250 alkyl acrylate group Chemical group 0.000 description 1
- 229940024606 amino acid Drugs 0.000 description 1
- 239000003242 anti bacterial agent Substances 0.000 description 1
- 239000002260 anti-inflammatory agent Substances 0.000 description 1
- 229940121363 anti-inflammatory agent Drugs 0.000 description 1
- 239000003963 antioxidant agent Substances 0.000 description 1
- 235000006708 antioxidants Nutrition 0.000 description 1
- 235000021342 arachidonic acid Nutrition 0.000 description 1
- 229940114079 arachidonic acid Drugs 0.000 description 1
- 125000000637 arginyl group Chemical class N[C@@H](CCCNC(N)=N)C(=O)* 0.000 description 1
- 235000010323 ascorbic acid Nutrition 0.000 description 1
- 239000011668 ascorbic acid Substances 0.000 description 1
- 239000003212 astringent agent Substances 0.000 description 1
- 125000002511 behenyl group Chemical group [H]C([*])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])[H] 0.000 description 1
- XVAMCHGMPYWHNL-UHFFFAOYSA-N bemotrizinol Chemical compound OC1=CC(OCC(CC)CCCC)=CC=C1C1=NC(C=2C=CC(OC)=CC=2)=NC(C=2C(=CC(OCC(CC)CCCC)=CC=2)O)=N1 XVAMCHGMPYWHNL-UHFFFAOYSA-N 0.000 description 1
- 239000007844 bleaching agent Substances 0.000 description 1
- KDYFGRWQOYBRFD-NUQCWPJISA-N butanedioic acid Chemical compound O[14C](=O)CC[14C](O)=O KDYFGRWQOYBRFD-NUQCWPJISA-N 0.000 description 1
- 229910052799 carbon Inorganic materials 0.000 description 1
- 239000001569 carbon dioxide Substances 0.000 description 1
- 229910002092 carbon dioxide Inorganic materials 0.000 description 1
- 239000001768 carboxy methyl cellulose Substances 0.000 description 1
- 235000010948 carboxy methyl cellulose Nutrition 0.000 description 1
- 239000008112 carboxymethyl-cellulose Substances 0.000 description 1
- 239000000679 carrageenan Substances 0.000 description 1
- 235000010418 carrageenan Nutrition 0.000 description 1
- 229920001525 carrageenan Polymers 0.000 description 1
- 229940113118 carrageenan Drugs 0.000 description 1
- 239000002738 chelating agent Substances 0.000 description 1
- 239000012459 cleaning agent Substances 0.000 description 1
- 235000017471 coenzyme Q10 Nutrition 0.000 description 1
- 229940110767 coenzyme Q10 Drugs 0.000 description 1
- ACTIUHUUMQJHFO-UPTCCGCDSA-N coenzyme Q10 Chemical compound COC1=C(OC)C(=O)C(C\C=C(/C)CC\C=C(/C)CC\C=C(/C)CC\C=C(/C)CC\C=C(/C)CC\C=C(/C)CC\C=C(/C)CC\C=C(/C)CC\C=C(/C)CCC=C(C)C)=C(C)C1=O ACTIUHUUMQJHFO-UPTCCGCDSA-N 0.000 description 1
- 229920001436 collagen Polymers 0.000 description 1
- 239000013065 commercial product Substances 0.000 description 1
- 150000001875 compounds Chemical class 0.000 description 1
- 238000001816 cooling Methods 0.000 description 1
- 238000005520 cutting process Methods 0.000 description 1
- ZAKOWWREFLAJOT-UHFFFAOYSA-N d-alpha-Tocopheryl acetate Natural products CC(=O)OC1=C(C)C(C)=C2OC(CCCC(C)CCCC(C)CCCC(C)C)(C)CCC2=C1C ZAKOWWREFLAJOT-UHFFFAOYSA-N 0.000 description 1
- 238000004042 decolorization Methods 0.000 description 1
- BTNBMQIHCRIGOU-UHFFFAOYSA-N delta-tocotrienol Natural products CC(=CCCC(=CCCC(=CCCOC1(C)CCc2cc(O)cc(C)c2O1)C)C)C BTNBMQIHCRIGOU-UHFFFAOYSA-N 0.000 description 1
- 238000004332 deodorization Methods 0.000 description 1
- 239000003599 detergent Substances 0.000 description 1
- 230000006866 deterioration Effects 0.000 description 1
- HOBAELRKJCKHQD-QNEBEIHSSA-N dihomo-γ-linolenic acid Chemical compound CCCCC\C=C/C\C=C/C\C=C/CCCCCCC(O)=O HOBAELRKJCKHQD-QNEBEIHSSA-N 0.000 description 1
- 238000007865 diluting Methods 0.000 description 1
- 239000006185 dispersion Substances 0.000 description 1
- PMMYEEVYMWASQN-UHFFFAOYSA-N dl-hydroxyproline Natural products OC1C[NH2+]C(C([O-])=O)C1 PMMYEEVYMWASQN-UHFFFAOYSA-N 0.000 description 1
- 229960000735 docosanol Drugs 0.000 description 1
- 229920002549 elastin Polymers 0.000 description 1
- 229940088598 enzyme Drugs 0.000 description 1
- IDGUHHHQCWSQLU-UHFFFAOYSA-N ethanol;hydrate Chemical compound O.CCO IDGUHHHQCWSQLU-UHFFFAOYSA-N 0.000 description 1
- 150000002169 ethanolamines Chemical class 0.000 description 1
- 150000002170 ethers Chemical class 0.000 description 1
- 230000001747 exhibiting effect Effects 0.000 description 1
- VZCCETWTMQHEPK-UHFFFAOYSA-N gamma-Linolensaeure Natural products CCCCCC=CCC=CCC=CCCCCC(O)=O VZCCETWTMQHEPK-UHFFFAOYSA-N 0.000 description 1
- VZCCETWTMQHEPK-QNEBEIHSSA-N gamma-linolenic acid Chemical compound CCCCC\C=C/C\C=C/C\C=C/CCCCC(O)=O VZCCETWTMQHEPK-QNEBEIHSSA-N 0.000 description 1
- 235000020664 gamma-linolenic acid Nutrition 0.000 description 1
- 229960002733 gamolenic acid Drugs 0.000 description 1
- 239000000499 gel Substances 0.000 description 1
- 239000003349 gelling agent Substances 0.000 description 1
- 235000009569 green tea Nutrition 0.000 description 1
- 239000003676 hair preparation Substances 0.000 description 1
- 239000005556 hormone Substances 0.000 description 1
- 229940088597 hormone Drugs 0.000 description 1
- 239000010903 husk Substances 0.000 description 1
- 229930195733 hydrocarbon Natural products 0.000 description 1
- 150000002430 hydrocarbons Chemical class 0.000 description 1
- 239000008309 hydrophilic cream Substances 0.000 description 1
- 229960002591 hydroxyproline Drugs 0.000 description 1
- 238000005470 impregnation Methods 0.000 description 1
- 238000002347 injection Methods 0.000 description 1
- 239000007924 injection Substances 0.000 description 1
- 230000009545 invasion Effects 0.000 description 1
- 239000003456 ion exchange resin Substances 0.000 description 1
- 229920003303 ion-exchange polymer Polymers 0.000 description 1
- WTFXARWRTYJXII-UHFFFAOYSA-N iron(2+);iron(3+);oxygen(2-) Chemical compound [O-2].[O-2].[O-2].[O-2].[Fe+2].[Fe+3].[Fe+3] WTFXARWRTYJXII-UHFFFAOYSA-N 0.000 description 1
- SZVJSHCCFOBDDC-UHFFFAOYSA-N iron(II,III) oxide Inorganic materials O=[Fe]O[Fe]O[Fe]=O SZVJSHCCFOBDDC-UHFFFAOYSA-N 0.000 description 1
- 229940119170 jojoba wax Drugs 0.000 description 1
- 239000003410 keratolytic agent Substances 0.000 description 1
- 150000002576 ketones Chemical class 0.000 description 1
- TYQCGQRIZGCHNB-JLAZNSOCSA-N l-ascorbic acid Chemical compound OC[C@H](O)[C@H]1OC(O)=C(O)C1=O TYQCGQRIZGCHNB-JLAZNSOCSA-N 0.000 description 1
- 229940071085 lauroyl glutamate Drugs 0.000 description 1
- 229940010454 licorice Drugs 0.000 description 1
- 239000000865 liniment Substances 0.000 description 1
- 238000004811 liquid chromatography Methods 0.000 description 1
- 235000020978 long-chain polyunsaturated fatty acids Nutrition 0.000 description 1
- 239000011777 magnesium Substances 0.000 description 1
- 229910052749 magnesium Inorganic materials 0.000 description 1
- 239000000463 material Substances 0.000 description 1
- 238000000691 measurement method Methods 0.000 description 1
- 229940073663 methyl trimethicone Drugs 0.000 description 1
- 235000013336 milk Nutrition 0.000 description 1
- 239000008267 milk Substances 0.000 description 1
- 210000004080 milk Anatomy 0.000 description 1
- 230000001333 moisturizer Effects 0.000 description 1
- 230000003020 moisturizing effect Effects 0.000 description 1
- 229910000403 monosodium phosphate Inorganic materials 0.000 description 1
- 235000019799 monosodium phosphate Nutrition 0.000 description 1
- 239000004745 nonwoven fabric Substances 0.000 description 1
- 235000016709 nutrition Nutrition 0.000 description 1
- 230000035764 nutrition Effects 0.000 description 1
- 239000002674 ointment Substances 0.000 description 1
- BARWIPMJPCRCTP-UHFFFAOYSA-N oleic acid oleyl ester Natural products CCCCCCCCC=CCCCCCCCCOC(=O)CCCCCCCC=CCCCCCCCC BARWIPMJPCRCTP-UHFFFAOYSA-N 0.000 description 1
- BARWIPMJPCRCTP-CLFAGFIQSA-N oleyl oleate Chemical compound CCCCCCCC\C=C/CCCCCCCCOC(=O)CCCCCCC\C=C/CCCCCCCC BARWIPMJPCRCTP-CLFAGFIQSA-N 0.000 description 1
- 150000007524 organic acids Chemical class 0.000 description 1
- 230000003647 oxidation Effects 0.000 description 1
- 238000007254 oxidation reaction Methods 0.000 description 1
- AFDXODALSZRGIH-UHFFFAOYSA-N p-coumaric acid methyl ether Natural products COC1=CC=C(C=CC(O)=O)C=C1 AFDXODALSZRGIH-UHFFFAOYSA-N 0.000 description 1
- 239000003002 pH adjusting agent Substances 0.000 description 1
- 239000002245 particle Substances 0.000 description 1
- JLFNLZLINWHATN-UHFFFAOYSA-N pentaethylene glycol Chemical compound OCCOCCOCCOCCOCCO JLFNLZLINWHATN-UHFFFAOYSA-N 0.000 description 1
- NBIIXXVUZAFLBC-UHFFFAOYSA-K phosphate Chemical compound [O-]P([O-])([O-])=O NBIIXXVUZAFLBC-UHFFFAOYSA-K 0.000 description 1
- 230000019612 pigmentation Effects 0.000 description 1
- 229920000058 polyacrylate Polymers 0.000 description 1
- XAEFZNCEHLXOMS-UHFFFAOYSA-M potassium benzoate Chemical compound [K+].[O-]C(=O)C1=CC=CC=C1 XAEFZNCEHLXOMS-UHFFFAOYSA-M 0.000 description 1
- 239000000843 powder Substances 0.000 description 1
- 238000012545 processing Methods 0.000 description 1
- 235000013772 propylene glycol Nutrition 0.000 description 1
- 229940116422 propylene glycol dicaprate Drugs 0.000 description 1
- 239000003223 protective agent Substances 0.000 description 1
- 239000012264 purified product Substances 0.000 description 1
- 239000002994 raw material Substances 0.000 description 1
- 239000011347 resin Substances 0.000 description 1
- 229920005989 resin Polymers 0.000 description 1
- 229940108325 retinyl palmitate Drugs 0.000 description 1
- 235000019172 retinyl palmitate Nutrition 0.000 description 1
- 239000011769 retinyl palmitate Substances 0.000 description 1
- 229940109850 royal jelly Drugs 0.000 description 1
- 239000002453 shampoo Substances 0.000 description 1
- 239000000344 soap Substances 0.000 description 1
- 229910052708 sodium Inorganic materials 0.000 description 1
- 239000001509 sodium citrate Substances 0.000 description 1
- NLJMYIDDQXHKNR-UHFFFAOYSA-K sodium citrate Chemical compound O.O.[Na+].[Na+].[Na+].[O-]C(=O)CC(O)(CC([O-])=O)C([O-])=O NLJMYIDDQXHKNR-UHFFFAOYSA-K 0.000 description 1
- AJPJDKMHJJGVTQ-UHFFFAOYSA-M sodium dihydrogen phosphate Chemical compound [Na+].OP(O)([O-])=O AJPJDKMHJJGVTQ-UHFFFAOYSA-M 0.000 description 1
- 229940045920 sodium pyrrolidone carboxylate Drugs 0.000 description 1
- 159000000000 sodium salts Chemical class 0.000 description 1
- HYRLWUFWDYFEES-UHFFFAOYSA-M sodium;2-oxopyrrolidine-1-carboxylate Chemical compound [Na+].[O-]C(=O)N1CCCC1=O HYRLWUFWDYFEES-UHFFFAOYSA-M 0.000 description 1
- 229960005078 sorbitan sesquioleate Drugs 0.000 description 1
- 239000000600 sorbitol Substances 0.000 description 1
- 239000008347 soybean phospholipid Substances 0.000 description 1
- 229940082787 spirulina Drugs 0.000 description 1
- 150000005846 sugar alcohols Polymers 0.000 description 1
- 235000020238 sunflower seed Nutrition 0.000 description 1
- 230000001629 suppression Effects 0.000 description 1
- 239000004094 surface-active agent Substances 0.000 description 1
- 238000003786 synthesis reaction Methods 0.000 description 1
- OGIDPMRJRNCKJF-UHFFFAOYSA-N titanium oxide Inorganic materials [Ti]=O OGIDPMRJRNCKJF-UHFFFAOYSA-N 0.000 description 1
- 235000019149 tocopherols Nutrition 0.000 description 1
- 229950009883 tocopheryl nicotinate Drugs 0.000 description 1
- 229930003802 tocotrienol Natural products 0.000 description 1
- 239000011731 tocotrienol Substances 0.000 description 1
- 235000019148 tocotrienols Nutrition 0.000 description 1
- 235000015961 tonic Nutrition 0.000 description 1
- 230000001256 tonic effect Effects 0.000 description 1
- 229960000716 tonics Drugs 0.000 description 1
- FGMPLJWBKKVCDB-UHFFFAOYSA-N trans-L-hydroxy-proline Natural products ON1CCCC1C(O)=O FGMPLJWBKKVCDB-UHFFFAOYSA-N 0.000 description 1
- 238000012546 transfer Methods 0.000 description 1
- 125000000391 vinyl group Chemical group [H]C([*])=C([H])[H] 0.000 description 1
- 229920002554 vinyl polymer Polymers 0.000 description 1
- 238000010792 warming Methods 0.000 description 1
- 229920003169 water-soluble polymer Polymers 0.000 description 1
- 238000004383 yellowing Methods 0.000 description 1
- 239000011787 zinc oxide Substances 0.000 description 1
- UHVMMEOXYDMDKI-JKYCWFKZSA-L zinc;1-(5-cyanopyridin-2-yl)-3-[(1s,2s)-2-(6-fluoro-2-hydroxy-3-propanoylphenyl)cyclopropyl]urea;diacetate Chemical compound [Zn+2].CC([O-])=O.CC([O-])=O.CCC(=O)C1=CC=C(F)C([C@H]2[C@H](C2)NC(=O)NC=2N=CC(=CC=2)C#N)=C1O UHVMMEOXYDMDKI-JKYCWFKZSA-L 0.000 description 1
- QUEDXNHFTDJVIY-UHFFFAOYSA-N γ-tocopherol Chemical class OC1=C(C)C(C)=C2OC(CCCC(C)CCCC(C)CCCC(C)C)(C)CCC2=C1 QUEDXNHFTDJVIY-UHFFFAOYSA-N 0.000 description 1
- 150000003789 δ-tocopherols Chemical class 0.000 description 1
- 235000019144 δ-tocotrienol Nutrition 0.000 description 1
- 239000011729 δ-tocotrienol Substances 0.000 description 1
- ODADKLYLWWCHNB-LDYBVBFYSA-N δ-tocotrienol Chemical compound OC1=CC(C)=C2O[C@@](CC/C=C(C)/CC/C=C(C)/CCC=C(C)C)(C)CCC2=C1 ODADKLYLWWCHNB-LDYBVBFYSA-N 0.000 description 1
Landscapes
- Cosmetics (AREA)
Description
本技術は、化粧料、皮膚外用剤、並びに(a)炭素数16〜22の多価不飽和脂肪酸及び(b)ビタミンE類を含有する組成物の変色を抑制するための剤に関する。 The present technology relates to cosmetics, external preparations for skin, and agents for suppressing discoloration of compositions containing (a) polyunsaturated fatty acids having 16 to 22 carbon atoms and (b) vitamin Es.
炭素数18〜22かつ分子構造中の不飽和数が2以上の遊離脂肪酸は、美白作用等の種々の目的で、化粧料又は皮膚外用剤に用いられることが多い。
例えば、特許文献1には、炭素数18〜22かつ分子構造中の不飽和数が2以上の遊離脂肪酸、その塩、あるいは一価又は二価アルコールとのエステルを活性成分として含有する化粧料が開示されている。
また、特許文献2には、(a)甘草から抽出された油溶性エキス、および(b)炭素数18〜22であって、その分子構造中の不飽和結合数が2以上である遊離脂肪酸、その塩及びそのエステルからなる群より選ばれた1種または2種以上の成分を配合したことを特徴とする美白化粧料が開示されている。
Free fatty acids having 18 to 22 carbon atoms and an unsaturated number of 2 or more in the molecular structure are often used in cosmetics or external preparations for skin for various purposes such as whitening action.
For example, Patent Document 1 describes a cosmetic containing as an active ingredient a free fatty acid having 18 to 22 carbon atoms and an unsaturated number of 2 or more in the molecular structure, a salt thereof, or an ester with a monohydric or divalent alcohol. It is disclosed.
Further, Patent Document 2 describes (a) an oil-soluble extract extracted from licorice, and (b) a free fatty acid having 18 to 22 carbon atoms and having 2 or more unsaturated bonds in its molecular structure. A whitening cosmetic containing one or more components selected from the group consisting of the salt and an ester thereof is disclosed.
本発明者らは、後記〔表1〕に示すように、炭素数16〜22の多価不飽和脂肪酸とビタミンE類とを混合した化粧料成分が経時的に変色していることに気づいた(試験例1〜3参照)。
一般的に、炭素数16〜22の多価不飽和脂肪酸は、酸化等による劣化を受けやすく経時的に不安定な成分であるとして知られている。また、ビタミンE類は、脂溶性ビタミンとして食品、医薬品及び化粧品等に広く用いられ、また抗酸化剤としても広く利用されている。
通常であれば、前記多価不飽和脂肪酸の劣化を、ビタミンE類がその抗酸化作用によって抑えられると考える。しかしながら、実際には、これらを混ぜた組成物で変色が発生した。
化粧料や皮膚外用剤等の製品において、成分(a)炭素数16〜22の多価不飽和脂肪酸及び成分(b)ビタミンE類を併用することが望まれる一方で、変色は製品の外観上好ましくなく、また変色が発生する製品の場合、用途が限定される可能性がある。
As shown in [Table 1] below, the present inventors have noticed that the cosmetic component, which is a mixture of polyunsaturated fatty acids having 16 to 22 carbon atoms and vitamin Es, is discolored over time. (See Test Examples 1 to 3).
In general, polyunsaturated fatty acids having 16 to 22 carbon atoms are known to be easily deteriorated by oxidation and the like and are unstable with time. In addition, vitamin Es are widely used as fat-soluble vitamins in foods, pharmaceuticals, cosmetics, etc., and are also widely used as antioxidants.
Normally, it is considered that the deterioration of the polyunsaturated fatty acid is suppressed by the antioxidant action of vitamin Es. However, in reality, discoloration occurred in the composition in which these were mixed.
In products such as cosmetics and external preparations for skin, it is desirable to use component (a) polyunsaturated fatty acids having 16 to 22 carbon atoms and component (b) vitamin E in combination, while discoloration is caused by the appearance of the product. In the case of unfavorable and discolored products, their use may be limited.
そこで、本技術は、成分(a)炭素数16〜22の多価不飽和脂肪酸及び成分(b)ビタミンE類を含む化粧料又は皮膚外用剤の変色を抑制することを主な目的とする。 Therefore, the main purpose of this technique is to suppress discoloration of cosmetics or skin external preparations containing component (a) polyunsaturated fatty acids having 16 to 22 carbon atoms and component (b) vitamin Es.
本発明者らは、成分(a)炭素数16〜22の多価不飽和脂肪酸及び成分(b)ビタミンE類を含む組成物の変色を抑制するため、この組成物と種々の植物抽出物との組み合わせを検討した。
後記〔表2〕に示すように、シャクヤク抽出物、ローズマリー抽出物及び緑茶抽出物の何れを使用した場合でも、これら植物抽出物を添加していない比較例1品と対比すると、かえって前記成分(a)及び前記成分(b)を含む組成物の変色が強くなってしまった。(比較例2〜4参照)。 しかしながら、本発明者らは、偶然にも、ハトムギ抽出物であれば、前記成分(a)及び(b)を含む組成物の変色を抑制することができることを見出し、本発明を完成させた。
In order to suppress discoloration of the composition containing the component (a) polyunsaturated fatty acid having 16 to 22 carbon atoms and the component (b) vitamin E, the present inventors have used this composition and various plant extracts. The combination of was examined.
As shown in [Table 2] below, regardless of which of the peony extract, rosemary extract, and green tea extract is used, the above-mentioned components are rather compared with the comparative example 1 product to which these plant extracts are not added. The discoloration of the composition containing (a) and the component (b) has become stronger. (See Comparative Examples 2 to 4). However, the present inventors have found that, by chance, the Coix seed extract can suppress discoloration of the composition containing the components (a) and (b), and completed the present invention.
すなわち、本技術は、以下のとおりである。
本技術は、次の成分(a)、成分(b)及び成分(c);
(a)炭素数16〜22の多価不飽和脂肪酸
(b)ビタミンE類
(c)ハトムギ抽出物
を含有する化粧料又は皮膚外用剤である。
That is, the present technology is as follows.
The present technology comprises the following components (a), component (b) and component (c);
(A) A cosmetic or skin external preparation containing a polyunsaturated fatty acid having 16 to 22 carbon atoms, (b) vitamin Es, and (c) Coix seed extract.
また、本技術は、ハトムギ抽出物を有効成分とする、次の成分(a)及び成分(b);
(a)炭素数16〜22の多価不飽和脂肪酸から選ばれる1種又は2種以上
(b)ビタミンE類から選ばれる1種又は2種以上、
を含有する組成物の変色を抑制する剤である。
In addition, the present technology comprises the following components (a) and (b), which contain Coix seed extract as an active ingredient.
(A) One or more selected from polyunsaturated fatty acids having 16 to 22 carbon atoms (b) One or more selected from vitamin Es,
It is an agent that suppresses discoloration of a composition containing.
前記成分(a)が、リノール酸であってもよく、これを含むものであってもよい。
前記成分(b)が、ビタミンEであってもよく、これを含むものであってもよい。
前記成分(a)と成分(b)の含有質量割合(a)/(b)が0.1〜10000であってもよい。
前記「成分(a)+成分(b)」と成分(c)の含有質量割合[(a)+(b)]/(c)が、0.1〜12000であってもよい。
前記成分(a)及び成分(b)による変色を抑制することであってもよい。
The component (a) may be linoleic acid or may contain it.
The component (b) may be vitamin E or may contain it.
The content mass ratio (a) / (b) of the component (a) and the component (b) may be 0.1 to 10000.
The content mass ratio [(a) + (b)] / (c) of the “component (a) + component (b)” and the component (c) may be 0.1 to 12000.
Discoloration due to the component (a) and the component (b) may be suppressed.
本技術によれば、成分(a)炭素数16〜22の多価不飽和脂肪酸及び成分(b)ビタミンE類を含む化粧料又は皮膚外用剤の変色を抑制することができる。
なお、ここに記載された効果は、必ずしも限定されるものではなく、本技術中に記載されたいずれかの効果であってもよい。
According to this technique, it is possible to suppress discoloration of cosmetics or skin external preparations containing component (a) polyunsaturated fatty acids having 16 to 22 carbon atoms and component (b) vitamin Es.
The effects described here are not necessarily limited, and may be any of the effects described in the present technology.
<化粧料又は皮膚外用剤>
本技術は、成分(a)炭素数16〜22の多価不飽和脂肪酸、成分(b)ビタミンE類、及び成分(c)ハトムギ抽出物を含有する組成物である。前記組成物は、化粧料又は皮膚外用剤であることが望ましい。
成分(c)ハトムギ抽出物を使用することにより、前記成分(a)及び前記成分(b)に起因する変色を抑制することができ、またこれら成分(a)及び成分(b)を含む組成物の変色、また化粧料又は皮膚外用剤の変色を抑制することができる。
また、本技術は、前記成分(a)、前記成分(b)及び前記成分(c)を含み、前記成分(a)及び前記成分(b)による変色を抑制する組成物、化粧料又は皮膚外用剤を提供することができる。
<Cosmetics or external preparations for skin>
The present technology is a composition containing a component (a) a polyunsaturated fatty acid having 16 to 22 carbon atoms, a component (b) vitamin Es, and a component (c) an adlay extract. It is desirable that the composition is a cosmetic or an external preparation for skin.
By using the component (c) Coix seed extract, discoloration caused by the component (a) and the component (b) can be suppressed, and a composition containing these components (a) and the component (b). It is possible to suppress the discoloration of Coix seeds and the discoloration of cosmetics or external preparations for skin.
In addition, the present technology includes the above-mentioned component (a), the above-mentioned component (b) and the above-mentioned component (c), and is used for external use of a composition, cosmetics or skin that suppresses discoloration due to the above-mentioned component (a) and the above-mentioned component (b). Agents can be provided.
一般的に「変色」を促進させる原因として、例えば、光(特に紫外線)、温度(特に熱、高温)、pH等がいわれ、経時的に変色することが問題視される。
通常、化粧料又は皮膚外用剤は製造後に梱包され一定期間保管されることが多く、その間に様々な温度環境や光にさらされても経時的に安定であることが求められる。とくに外観は化粧料や皮膚外用剤にとって重要な品質であることから、使用者が開封したときや使用期間中に製品が前記成分(a)及び成分(b)による経時的な変色を抑制できることが重要となる。
本技術において、前記成分(a)及び前記成分(b)による経時的な変色を常温において長期間抑制できることは有利な点であり、後記〔実施例〕からすると常温で少なくとも3年以上抑制することが可能と考える。
Generally, as a cause of promoting "discoloration", for example, light (particularly ultraviolet rays), temperature (particularly heat, high temperature), pH and the like are said, and discoloration over time is regarded as a problem.
Usually, cosmetics or external preparations for skin are often packed after production and stored for a certain period of time, and are required to be stable over time even when exposed to various temperature environments and light during that period. In particular, since the appearance is an important quality for cosmetics and external preparations for skin, it is possible to suppress discoloration of the product over time due to the components (a) and (b) when the user opens the package or during the period of use. It becomes important.
In the present technology, it is an advantage that discoloration over time due to the component (a) and the component (b) can be suppressed at room temperature for a long period of time, and according to the following [Example], it should be suppressed at room temperature for at least 3 years or more. I think it is possible.
また、「変色」は、色差:50℃と5℃にそれぞれ静置し一定期間後の測色値のΔEを比較することで判断することができる。
この色差が好ましくは、ΔE6未満、より好ましくはΔE4.5未満、さらに好ましくはΔE4.0以下であることが好適である。この色差のΔEが小さいほど、変色の程度が少ないと判断できる。
Further, "discoloration" can be determined by allowing the color difference: 50 ° C. and 5 ° C., respectively, and comparing the ΔE of the color measurement values after a certain period of time.
This color difference is preferably less than ΔE6, more preferably less than ΔE4.5, and even more preferably ΔE4.0 or less. It can be determined that the smaller the ΔE of this color difference, the smaller the degree of discoloration.
<長鎖多価不飽和脂肪酸>
本技術で使用される成分(a)である、炭素数16〜22の多価不飽和脂肪酸は、その分子構造中の不飽和結合数が2又は3以上を有するものである。当該成分(a)は、後述する成分(b)ビタミンE類と併用することで変色が生じると考えられる。
前記成分(a)多価不飽和脂肪酸は、遊離脂肪酸、その塩(一般的に使用可能な塩)のいずれの状態でもよく、このうちから1種又は2種以上を選択することができる。前記多価不飽和脂肪酸は、遊離脂肪酸の状態であることが好ましく、また不飽和結合が2個のものが好ましい。
また、前記多価不飽和脂肪酸の炭素数は、好ましくは18〜22である。
前記成分(a)は、市販品を使用すればよく、分離精製品又は合成品を使用することが好ましい。
<Long-chain polyunsaturated fatty acids>
The polyunsaturated fatty acid having 16 to 22 carbon atoms, which is the component (a) used in the present technology, has an unsaturated bond number of 2 or 3 or more in its molecular structure. It is considered that the component (a) is discolored when used in combination with the component (b) vitamin E described later.
The component (a) polyunsaturated fatty acid may be in any state of a free fatty acid and a salt thereof (a salt that can be generally used), and one or more of them can be selected. The polyunsaturated fatty acid is preferably in the state of a free fatty acid, and preferably has two unsaturated bonds.
The carbon number of the polyunsaturated fatty acid is preferably 18 to 22.
As the component (a), a commercially available product may be used, and it is preferable to use a separated purified product or a synthetic product.
前記成分(a)は、紫外線による皮膚の乾燥や、シミ・ソバカス等の色素沈着の消失・予防作用を有する。このため、前記成分(a)を、エモリエント作用成分や美白用成分として使用することができる。そして、前記成分(a)を含有させることでエモリエント用又は美白用の組成物(例えば、化粧料、皮膚外用剤等)とすることができる。 The component (a) has an action of drying the skin by ultraviolet rays and eliminating / preventing pigmentation such as spots and freckles. Therefore, the component (a) can be used as an emollient acting component or a whitening component. Then, by containing the component (a), a composition for emollients or whitening (for example, cosmetics, external preparations for skin, etc.) can be obtained.
前記遊離脂肪酸としては、その代表的なものとして、リノール酸、α−リノレン酸、γ−リノレン酸、ジホモ−γ−リノレン酸、アラキドン酸、エイコサジエン酸、エイコサペンタエン酸(EPA)、ドコサヘキサエン酸(DHA)等が挙げられ、このうちから1種又は2種以上を選択することができる。
前記遊離脂肪酸の塩としては、例えば、ナトリウム塩、カリウム塩等の金属塩;アルギニン塩、リジン塩等のアミノ酸塩;トリエタノールアミン塩、モノエタノールアミン塩等のアミン塩等が挙げられ、このうちから1種又は2種以上を選択することができる。
Typical examples of the free fatty acid include linoleic acid, α-linolenic acid, γ-linolenic acid, dihomo-γ-linolenic acid, arachidonic acid, eicosapentaenoic acid, eicosapentaenoic acid (EPA), and docosahexaenoic acid (DHA). ), Etc., and one type or two or more types can be selected from these.
Examples of the salt of the free fatty acid include metal salts such as sodium salt and potassium salt; amino acid salts such as arginine salt and lysine salt; amine salts such as triethanolamine salt and monoethanolamine salt, and the like. One type or two or more types can be selected from.
本技術において、組成物中に前記多価不飽和脂肪酸のエステルが含まれる場合、このエステル誘導体が、温度やpH、経時等により分解されて遊離多価不飽和脂肪酸が生成されることがあるが、本技術によればこの遊離多価不飽和脂肪酸とビタミンE類による変色を抑制することができる。 In the present technology, when the composition contains an ester of the polyunsaturated fatty acid, the ester derivative may be decomposed by temperature, pH, aging, etc. to produce a free polyunsaturated fatty acid. According to this technology, discoloration due to this free polyunsaturated fatty acid and vitamin Es can be suppressed.
前記成分(a)のうち、リノール酸又はその塩は、成分(b)ビタミンE類と混合することで、変色を生じさせやすいと考えられ、また、リノール酸は、美白作用及びエモリエント作用もあり、臭いも少ない。
このようなことから、成分(a)のうち、リノール酸又はその塩(以下、リノール酸類ともいう)が好ましく、また、リノール酸類(好適には、リノール酸)を含む前記成分(a)が好ましい。また、本技術において、リノール酸類以外の前記成分(a)も含むことは効能を損なわない範囲において可能である。
本技術のエモリエント作用とは、皮膚を柔軟にする作用及び皮膚の保湿作用をいう。
Of the component (a), linoleic acid or a salt thereof is considered to easily cause discoloration when mixed with the component (b) vitamin Es, and linoleic acid also has a whitening effect and an emollient effect. , There is little odor.
For this reason, among the component (a), linoleic acid or a salt thereof (hereinafter, also referred to as linoleic acid) is preferable, and the component (a) containing linoleic acid (preferably linoleic acid) is preferable. .. Further, in the present technology, it is possible to include the above-mentioned component (a) other than linoleic acids as long as the efficacy is not impaired.
The emollient action of the present technology refers to an action of softening the skin and an action of moisturizing the skin.
本技術で使用される成分(a)の含有量又は使用量は、前記組成物中、遊離脂肪酸換算として0.0001質量%〜5質量%が好ましく、0.001質量%〜3質量%がより好ましく、0.01質量%〜1質量%がさらに好ましい。
また、本技術で使用されるリノール酸類の含有量又は使用量は、前記組成物中、化粧料又は皮膚外用剤中、0.0001質量%〜5質量%が好ましく、0.001質量%〜3質量%がより好ましく、0.01質量%〜1質量%がさらに好ましい。
The content or amount of the component (a) used in the present technology is preferably 0.0001% by mass to 5% by mass, more preferably 0.001% by mass to 3% by mass in terms of free fatty acids in the composition. It is preferable, and more preferably 0.01% by mass to 1% by mass.
The content or amount of linoleic acids used in the present technology is preferably 0.0001% by mass to 5% by mass, preferably 0.001% by mass to 3% in the composition, cosmetics or external preparation for skin. By mass% is more preferable, and 0.01% by mass to 1% by mass is further preferable.
本技術で使用される成分(b)ビタミンE類として、トコフェロール(例えば、α−,β−,γ−,δ−トコフェロール)及びトコトリエノール(例えば、α−,β−,γ−,δ−トコトリエノール等)等のビタミンE;ビタミンEアセテート、ビタミンEニコチネート、α−トコフェロール 2−L−アスコルビン酸リン酸ジエステル等のビタミンE誘導体(好適にはビタミンEエステル);これらの塩(一般的に使用可能な塩)等が挙げられ、このうちから1種又は2種以上を選択することができる。
前記成分(b)は、市販品を使用すればよく、天然由来であっても合成品であっても良い。また天然由来である場合は分離精製品が好ましい。
Ingredients (b) Vitamin E used in this technology include tocopherols (eg, α-, β-, γ-, δ-tocopherols) and tocotrienol (eg, α-, β-, γ-, δ-tocotrienol, etc.) ) Etc. Vitamin E; Vitamin E acetate, Vitamin E nicotinate, α-tocopherol 2-L-ascorbic acid phosphate diester and other vitamin E derivatives (preferably vitamin E ester); salts of these (generally usable) Salt) and the like, and one or more of them can be selected.
As the component (b), a commercially available product may be used, and the component (b) may be of natural origin or a synthetic product. Further, when it is naturally derived, a separated refined product is preferable.
一般的に、合成ビタミンEは、素材原料を化学合成にて製造されたもの(例えば、dl−α−トコフェロール等)である。 In general, synthetic vitamin E is a raw material produced by chemical synthesis (for example, dl-α-tocopherol or the like).
また、一般的に、天然由来ビタミンEは、植物油又は微生物(例えば、藻類等)の生産油から抽出したものである。このうち、植物油由来のビタミンEが、化粧品等に多く利用されているので、好ましい。この植物として、大豆、ヒマワリ種子、コムギ胚芽、菜種等が挙げられる。また藻類としては、ユーグレナ、クロレラ、スピルリナ等が挙げられる。
また、天然由来ビタミンEとして、例えば、抽出後に有機酸(例えば、酢酸やコハク酸等)等を付加して安定化したもの(例えば、酢酸d−α−トコフェノール等を含むビタミンE誘導体)及び抽出後誘導体としないもの(d−α−トコフェロール等を含むビタミンE)等が挙げられる。
In general, naturally-derived vitamin E is extracted from vegetable oils or oils produced by microorganisms (for example, algae). Of these, vitamin E derived from vegetable oil is preferable because it is widely used in cosmetics and the like. Examples of this plant include soybean, sunflower seed, wheat germ, rapeseed and the like. Examples of algae include Euglena, Chlorella, Spirulina and the like.
Further, as naturally derived vitamin E, for example, those stabilized by adding an organic acid (for example, acetic acid, succinic acid, etc.) after extraction (for example, a vitamin E derivative containing d-α-tocophenol acetate, etc.) and Examples thereof include those that are not derived after extraction (vitamin E containing d-α-tocopherol and the like).
一般的に、植物油由来のビタミンE又は藻類由来のビタミンEは、α―トコフェロール、β―トコフェロール、γ―トコフェロール、δ―トコフェロールを含み、これらから選ばれる1種又は2種以上の混合物である。通常、このうちの、2種、3種又は4種を含有していることが多い。 In general, vitamin E derived from vegetable oil or vitamin E derived from algae includes α-tocopherol, β-tocopherol, γ-tocopherol, and δ-tocopherol, and is one or a mixture of two or more selected from these. Usually, it often contains 2, 3 or 4 of these.
一般的に市販されている植物油由来ビタミンEの組成比は、α―トコフェロール5〜20%、β―トコフェロール0〜10%、γ―トコフェロール30〜90%、δ―トコフェロール5〜60%などがある。この市販品の植物油由来ビタミンEは、別名として、天然ビタミンEとも呼ばれている。 The composition ratio of vitamin E derived from vegetable oil that is generally commercially available includes α-tocopherol 5 to 20%, β-tocopherol 0 to 10%, γ-tocopherol 30 to 90%, and δ-tocopherol 5 to 60%. .. This commercially available vegetable oil-derived vitamin E is also known as natural vitamin E.
前記成分(b)ビタミンE類は、前記成分(a)多価不飽和脂肪酸と混合することで、経時的な変色を生じさせやすいと考えられる。また、ビタミンEは、抗酸化作用、血行促進作用があり、コストや安全性等の点からよく利用されている。 It is considered that the component (b) vitamin Es are likely to cause discoloration over time when mixed with the component (a) polyunsaturated fatty acid. Vitamin E has an antioxidant effect and a blood circulation promoting effect, and is often used in terms of cost and safety.
前記成分(b)のうち、ビタミンEが好ましい。ビタミンEとして、合成ビタミンEであってもよいし、天然由来ビタミンEであってもよい。また、本技術において、ビタミンE以外の前記成分(b)も含むことは効能を損なわない範囲において可能である。
前記ビタミンEのうち、トコフェロールが好ましい。トコフェロールとして、合成トコフェロールであってもよいし、天然トコフェロールであってもよい。
このうち、α―トコフェロール、β―トコフェロール、γ―トコフェロール及びδ―トコフェロールから選ばれる混合物である点で、天然トコフェロールが好ましい。また、混合物であれば、合成トコフェロールでもよい。
Of the components (b), vitamin E is preferable. As the vitamin E, it may be a synthetic vitamin E or a naturally occurring vitamin E. Further, in the present technology, it is possible to include the above-mentioned component (b) other than vitamin E as long as the efficacy is not impaired.
Of the vitamin E, tocopherol is preferable. The tocopherol may be synthetic tocopherol or natural tocopherol.
Of these, natural tocopherol is preferable because it is a mixture selected from α-tocopherol, β-tocopherol, γ-tocopherol and δ-tocopherol. Further, if it is a mixture, synthetic tocopherol may be used.
本技術で使用される成分(b)の含有量又は使用量は、前記組成物中、0.00001質量%〜5質量%が好ましく、0.0001質量%〜3質量%がより好ましく、0.001質量%〜1質量%がさらに好ましい。
また、本技術で使用されるビタミンEの含有量又は使用量は、前記組成物中、0.00001質量%〜5質量%が好ましく、0.0001質量%〜3質量%がより好ましく、0.001質量%〜1質量%がさらに好ましい。
The content or amount of the component (b) used in the present technology is preferably 0.00001% by mass to 5% by mass, more preferably 0.0001% by mass to 3% by mass, and 0. 001% by mass to 1% by mass is more preferable.
The content or amount of vitamin E used in the present technology is preferably 0.00001% by mass to 5% by mass, more preferably 0.0001% by mass to 3% by mass, and 0. 001% by mass to 1% by mass is more preferable.
本技術で使用される成分(c)のハトムギ抽出物とは、イネ科(Poaceae)ジュズダマ属(Coix)ハトムギ(Coix lacryma-jobi var. ma-yuen)の抽出物である。ハトムギは、中国、インドシナ原産で日本に古くから渡来し、西南部の暖地で栽培される一年草で、鎮痛、消炎、排膿効果のある生薬として用いられてきた。また、ハトムギの種皮を除いた種子を生薬「ヨクイニン(薏苡仁)」、ヨクイニン(日本薬局方)と呼ぶ。 The Coix seed extract of the component (c) used in the present technology is an extract of the Gramineae (Poaceae) Coix Coix Coix (Coix lacryma-jobi var. Ma-yuen). Coix seeds are an annual plant native to China and Indochina that have been introduced to Japan for a long time and are cultivated in the warm regions of the southwestern region. In addition, the seeds of Coix seeds excluding the seed coat are called crude drugs "Yokuinin (薏 Tojin)" and Yokuinin (Japanese Pharmacopoeia).
前記植物の抽出に使用する部位として、何れの部位を用いてもよいが、例えば、種子、種子殻、種皮、葉及び茎等が挙げられ、これらから1種又は2種以上を選択したものを用いることができる。このうち、本技術の変色抑制の点で、種子が好ましく、さらに種皮を除いた種子が好適である。 Any part may be used as the part used for the extraction of the plant, and examples thereof include seeds, seed husks, seed coats, leaves and stems, and one or more selected from these are selected. Can be used. Of these, seeds are preferable, and seeds without seed coats are preferable from the viewpoint of suppressing discoloration of the present technology.
前記植物抽出の部位は、乾燥、粉砕、切断又は細断等の適宜処理を施したものを使用することができ、当該処理後に抽出を行うことが望ましい。 As the plant extraction site, one that has been appropriately treated such as drying, crushing, cutting or shredding can be used, and it is desirable to perform extraction after the treatment.
前記植物の抽出方法は、特に限定されない。抽出は、前記ハトムギを一定温度(低温、室温又は加温)下にて、所定期間、浸漬等にて、抽出溶媒を用いて行えばよい。 The method for extracting the plant is not particularly limited. Extraction may be carried out by using an extraction solvent by immersing the Coix seeds at a constant temperature (low temperature, room temperature or warming) for a predetermined period of time.
前記抽出溶媒として、特に限定されないが、例えば、水、有機溶媒等が挙げられ、これらから1種又は2種以上選択することができる。また、超臨界状態の二酸化炭素や水等を用いることもできる。 The extraction solvent is not particularly limited, and examples thereof include water, an organic solvent, and the like, and one or more of these can be selected. Further, carbon dioxide, water, etc. in a supercritical state can also be used.
前記有機溶媒として、例えば、アルコール類;アセトン等のケトン類;エチルエーテル等のエーテル類;酢酸エチル等のエステル類;ヘキサン、ベンゼン等の炭化水素等から選ばれる1種又は2種以上のものを用いることができる。 As the organic solvent, for example, one or more selected from alcohols; ketones such as acetone; ethers such as ethyl ether; esters such as ethyl acetate; hydrocarbons such as hexane and benzene. Can be used.
前記アルコール類として、例えば、低級1価アルコール(例えば、メタノール、エタノール等);液状多価アルコール(例えば、1,3−ブチレングリコール、プロピレングリコール、グリセリン等)等が挙げられる。 Examples of the alcohols include lower monohydric alcohols (eg, methanol, ethanol, etc.); liquid polyhydric alcohols (eg, 1,3-butylene glycol, propylene glycol, glycerin, etc.) and the like.
前記アルコール類は、1価アルコール類及び2価アルコール類が好ましく、アルコール類の炭素数は1〜5程度であるのが好ましい。 The alcohols are preferably monohydric alcohols and divalent alcohols, and the alcohols preferably have about 1 to 5 carbon atoms.
前記抽出溶媒のうち、水及び/又はアルコール類(好適には炭素数1〜4)が好ましい。前記アルコール類として、メタノール、エタノール、プロピレングリコール及び1,3−ブチレングリコール(1,3−BG)から選ばれる1種又は2種以上のものが好ましい。
この抽出溶媒のうち、さらに好ましくは、水、エタノール及び1,3−ブチレングリコールから選ばれる1種又は2種以上の混合のものであり、より好ましくは、水、エタノール、1,3−ブチレングリコール、エタノール水混合溶液、1,3−ブチレングリコール水混合溶液であり、よりさらに好ましくは含水エタノールである。
また、アルコール水溶液の場合、アルコール類濃度(V/V)は、好ましくは0〜100体積%であり、より好ましくは20〜80体積%であることが好適である。
Of the extraction solvents, water and / or alcohols (preferably having 1 to 4 carbon atoms) are preferable. As the alcohols, one or more alcohols selected from methanol, ethanol, propylene glycol and 1,3-butylene glycol (1,3-BG) are preferable.
Of these extraction solvents, one or a mixture of one or more selected from water, ethanol and 1,3-butylene glycol is more preferable, and water, ethanol and 1,3-butylene glycol are more preferable. , Ethanol water mixed solution, 1,3-butylene glycol water mixed solution, and even more preferably hydrous ethanol.
In the case of an aqueous alcohol solution, the alcohol concentration (V / V) is preferably 0 to 100% by volume, more preferably 20 to 80% by volume.
前記ハトムギ抽出物の好ましい抽出方法の例として、前記ハトムギを、前記抽出溶媒にて、室温(例えば1〜30℃程度)又は加温(例えば30〜100℃程度)で、5分間〜7日間抽出を行う方法が挙げられる。このときの抽出溶媒として、水、アルコール類、又は水−アルコール類混合液の何れかが好ましく、さらに好ましくは、アルコール類及び水−アルコール類混合液である。
前記抽出は、室温抽出又は加温抽出のいずれでもよい。室温(好適には、10〜30℃)抽出で1〜7日間であるのが好ましい。また、加温(40〜90℃)抽出で1〜12時間であるのが好ましい。
As an example of a preferable extraction method of the Coix seed extract, the Coix seeds are extracted with the extraction solvent at room temperature (for example, about 1 to 30 ° C.) or warmed (for example, about 30 to 100 ° C.) for 5 minutes to 7 days. There is a way to do this. As the extraction solvent at this time, any of water, alcohols, or a water-alcohol mixture is preferable, and an alcohol and a water-alcohol mixture are more preferable.
The extraction may be either room temperature extraction or warm extraction. Extraction at room temperature (preferably 10 to 30 ° C.) is preferably for 1 to 7 days. Further, it is preferable that the extraction is performed by heating (40 to 90 ° C.) for 1 to 12 hours.
本技術のハトムギ抽出物は、そのまま有効成分として使用してもよいし、効果を損なわない範囲で夾雑物等不純物を除去するため又は効果を高めるために、適宜、公知の分離精製方法にて処理してもよい。例えば、必要に応じて、さらに抽出溶媒の除去、濾過、イオン交換樹脂等の脱臭、脱色等の精製処理を施した後に用いることもできる。また、液体クロマトグラフィー等の分離手段を用いて、活性の高い画分を用いることができる。 The Coix seed extract of the present technology may be used as it is as an active ingredient, or may be appropriately treated by a known separation and purification method in order to remove impurities such as impurities or enhance the effect within a range that does not impair the effect. You may. For example, if necessary, it can be used after further purification treatment such as removal of extraction solvent, filtration, deodorization of ion exchange resin, and decolorization. In addition, a highly active fraction can be used by using a separation means such as liquid chromatography.
本技術のハトムギ抽出物は、抽出液単独で又は異なる抽出方法にて得られた抽出液を混合してそのまま用いるか、又は当該抽出物を希釈、濃縮又は乾燥させて、液状、粉末状、ペースト状に調製して用いることもできる。 The honeybee extract of the present technology can be used as it is by using the extract alone or by mixing the extracts obtained by different extraction methods, or by diluting, concentrating or drying the extract, in a liquid, powdery or paste form. It can also be prepared and used.
そして、後記実施例に示すように、本技術の成分(c)ハトムギ抽出物は、(a)炭素数16〜22の多価不飽和脂肪酸から選ばれる1種又は2種以上、(b)ビタミンE類から選ばれる1種又は2種以上を含むことにより生じる変色を抑制する作用を有する。すなわち、前記成分(c)を有効成分として含有する、前記成分(a)及び前記成分(b)を含む組成物の変色抑制剤を提供することができる。なお、この前記成分(a)及び前記成分(b)を含む組成物は、化粧料又は皮膚外用剤であることが、後記〔実施例〕の結果より、好ましい。 Then, as shown in Examples below, the component (c) Coix seed extract of the present technology is (a) one or more selected from polyunsaturated fatty acids having 16 to 22 carbon atoms, and (b) vitamins. It has an effect of suppressing discoloration caused by containing one kind or two or more kinds selected from class E. That is, it is possible to provide a discoloration inhibitor of the composition containing the component (a) and the component (b), which contains the component (c) as an active ingredient. In addition, it is preferable that the composition containing the component (a) and the component (b) is a cosmetic or an external preparation for skin, based on the results of the following [Examples].
また、本技術の成分(c)ハトムギ抽出物は、前記成分(a)及び前記成分(b)による変色を抑制する方法に使用することができる。また、前記成分(a)及び前記成分(b)を含有する組成物の変色を抑制するための、成分(c)ハトムギ抽出物を提供することができる。また、前記成分(a)及び前記成分(b)による変色を抑制できる剤又は組成物を製造するために、成分(c)ハトムギ抽出物を使用することができる。 Further, the Coix seed extract of the component (c) of the present technology can be used as a method for suppressing discoloration due to the component (a) and the component (b). Further, it is possible to provide an Coix seed extract of the component (c) for suppressing discoloration of the component (a) and the composition containing the component (b). Further, in order to produce an agent or composition capable of suppressing discoloration due to the component (a) and the component (b), the Coix seed extract of the component (c) can be used.
本技術で使用される成分(c)の含有量又は使用量は、前記組成物中、エキス純分として0.00001質量%〜5質量%が好ましく、0.00005質量%〜1質量%がより好ましく、0.0001質量%〜0.5質量%がさらに好ましい。
また、本技術で使用されるイネ科(Poaceae)ジュズダマ属(Coix)ハトムギ(Coix lacryma-jobi var. ma-yuen)抽出物(好適には、種皮を除いた種子抽出物)の含有量又は使用量は、前記組成物中、エキス純分として0.00001質量%〜5質量%が好ましく、0.00005質量%〜1質量%がより好ましく、0.0001質量%〜0.5質量%がさらに好ましい。
The content or amount of the component (c) used in the present technology is preferably 0.00001% by mass to 5% by mass, more preferably 0.00005% by mass to 1% by mass, as the pure extract content in the composition. It is preferably 0.0001% by mass to 0.5% by mass, more preferably 0.0001% by mass.
In addition, the content or use of Poaceae Coix Coix Coix Coix lacryma-jobi var. Ma-yuen extract (preferably seed extract excluding seed coat) used in this technology. The amount of the pure extract in the composition is preferably 0.00001% by mass to 5% by mass, more preferably 0.00005% by mass to 1% by mass, and further preferably 0.0001% by mass to 0.5% by mass. preferable.
本技術の、組成物、化粧料若しくは皮膚外用剤、又は変色抑制方法におけるpHは、特に限定されず、適宜pH調整剤にて調整することができる。
本技術のpH(20℃)は、好ましくは3.0〜9.0であり、より好ましくは4.0〜8.0である。当該pHに調整することで、前記成分(c)ハトムギ抽出物が、前記成分(a)及び前記成分(b)による変色を抑制し易いので、有利である。
また、前記成分(a)〜前記成分(c)を混合した後のpH(20℃)は、好ましくは3.0〜9.0、より好ましくは4.0〜8.0に調整することが、経時的な変色を抑制し易い点で、好適である。
また、前記成分(a)及び前記成分(b)は水存在下で変色が生じ易いので、水を含む組成物に、成分(c)ハトムギ抽出物を変色抑制のために使用することが好ましい。
The pH of the composition, cosmetics or external preparation for skin, or the method for suppressing discoloration of the present technology is not particularly limited and can be appropriately adjusted with a pH adjuster.
The pH (20 ° C.) of the present technology is preferably 3.0 to 9.0, more preferably 4.0 to 8.0. Adjusting to the pH is advantageous because the component (c) Coix seed extract can easily suppress discoloration due to the component (a) and the component (b).
The pH (20 ° C.) after mixing the components (a) to (c) can be adjusted to preferably 3.0 to 9.0, more preferably 4.0 to 8.0. , It is preferable in that it is easy to suppress discoloration over time.
Further, since the component (a) and the component (b) are likely to be discolored in the presence of water, it is preferable to use the component (c) Coix seed extract in the composition containing water to suppress the discoloration.
本技術で使用される前記成分(a)と成分(c)の含有(使用)質量割合(a)/(c)は、好ましくは0.1〜1000、より好ましくは0.3〜500、より好ましくは0.5〜100である。
本技術で使用される前記成分(b)と成分(c)の含有(使用)質量割合(b)/(c)は、好ましくは0,003〜10000、より好ましくは0.01〜1000、より好ましくは0.1〜100である。
The content (use) mass ratio (a) / (c) of the component (a) and the component (c) used in the present technology is preferably 0.1 to 1000, more preferably 0.3 to 500, and more. It is preferably 0.5 to 100.
The content (use) mass ratio (b) / (c) of the component (b) and the component (c) used in the present technology is preferably 0.003 to 10000, more preferably 0.01 to 1000, and more. It is preferably 0.1 to 100.
本技術で使用される前記成分(a)多価不飽和脂肪酸と前記成分(b)ビタミンE類の含有質量割合(a)/(b)が、好ましくは0.1〜10000、より好ましくは0.3〜1000、さらに好ましくは0.5〜500である。このような範囲にすることにより、前記成分(a)及び成分(b)の効能をさらに良好に発揮させることができる。 The content mass ratio (a) / (b) of the component (a) polyunsaturated fatty acid and the component (b) vitamin E used in the present technology is preferably 0.1 to 10000, more preferably 0. .3 to 1000, more preferably 0.5 to 500. By setting the range in such a range, the effects of the component (a) and the component (b) can be further exerted.
本技術で使用される「成分(a)+成分(b)」と成分(c)の含有(使用)質量割合[(a)+(b)]/(c)が、好ましくは0.1〜12000、より好ましくは0.3〜6000、より好ましくは0.5〜3000である。このような範囲にすることにより、前記成分(a)及び成分(b)の効能をさらに良好に発揮させつつ、より良好に変色抑制を行うことができる。 The "component (a) + component (b)" used in the present technology and the content (use) mass ratio of the component (c) [(a) + (b)] / (c) are preferably 0.1 to 1. It is 12000, more preferably 0.3 to 6000, and more preferably 0.5 to 3000. By setting the range to such a range, it is possible to suppress discoloration more satisfactorily while exerting the effects of the component (a) and the component (b) more satisfactorily.
本技術の変色抑制の対象となる組成物は、特に限定されないが、少なくとも前記(a)成分及び/又は前記成分(b)を含むことによって、前記成分(a)及び前記成分(b)の少なくとも何れか一方又は両方の効能を発揮する組成物が好ましい。
また、本技術の変色抑制の対象となる組成物(好適には、化粧料又は皮膚外用剤)は、例えば、皮膚外用剤、化粧料、美白剤、デオドラント剤、洗剤等が挙られる。このうち、エモリエント効果を期待するスキンケアのために使用する組成物等が好ましい。
The composition to be suppressed in discoloration of the present technology is not particularly limited, but by containing at least the component (a) and / or the component (b), at least the component (a) and the component (b) are contained. A composition exhibiting the effects of either one or both is preferable.
In addition, examples of the composition (preferably a cosmetic or an external preparation for skin) to be suppressed from discoloration of the present technology include an external preparation for skin, a cosmetic, a whitening agent, a deodorant, a detergent and the like. Of these, compositions used for skin care that are expected to have an emollient effect are preferable.
また、本技術の成分(a)〜成分(c)を含む組成物、化粧料又は皮膚外用剤には、必要に応じて本技術の効果を損なわない範囲で、通常、化粧料や医薬部外品、医薬品等の皮膚外用剤等の種々の製剤に使用される成分を加えることができる。当該成分として、例えば、水、油剤、界面活性剤、金属セッケン、ゲル化剤、粉体、アルコール類、水溶性高分子、皮膜形成剤、樹脂、紫外線防御剤、包接化合物、抗菌剤、香料、消臭剤、塩類、pH調整剤、清涼剤、動物・微生物由来抽出物、植物抽出物、血行促進剤、収斂剤、抗脂漏剤、美白剤、抗炎症剤、活性酸素消去剤、細胞賦活剤、保湿剤、キレート剤、角質溶解剤、酵素、ホルモン類、ビタミン類等が挙げられる。これらから適宜1種又は2種以上選択して使用することができる。 In addition, the compositions, cosmetics or external preparations containing the components (a) to (c) of the present technology are usually used for cosmetics and quasi-drugs as long as the effects of the present technology are not impaired. Ingredients used in various preparations such as external preparations for skin such as products and pharmaceuticals can be added. Examples of the components include water, oil agents, surfactants, metal soaps, gelling agents, powders, alcohols, water-soluble polymers, film-forming agents, resins, ultraviolet protective agents, inclusion compounds, antibacterial agents, and fragrances. , Deodorants, salts, pH adjusters, refreshing agents, animal / microorganism-derived extracts, plant extracts, blood circulation promoters, astringents, anti-fat leak agents, whitening agents, anti-inflammatory agents, active oxygen scavengers, cells Examples include activators, moisturizers, chelating agents, keratolytic agents, enzymes, hormones, vitamins and the like. From these, one kind or two or more kinds can be appropriately selected and used.
本技術の成分(a)〜成分(c)を含む組成物、化粧料又は皮膚外用剤は、公知の製法によって得ることができる。
本技術の化粧料又は皮膚外用剤として、具体的には、例えば、乳液、クリーム、化粧水、美容液、パック、オールインワンジェル、日焼け止め、洗浄料などの基礎化粧料、メイク下地、BBクリーム、ファンデーション、頬紅、口紅等のメイクアップ化粧料、養毛料、ヘアトニック、シャンプー、リンス等の頭髪用化粧料、分散液、軟膏、液剤、エアゾール、貼付剤、パップ剤、リニメント剤等のいずれの形態であってもよい。美白効果やエモリエント効果等を期待するような、肌に使用する化粧料又は皮膚外用剤が好ましい。
The composition, cosmetic or external preparation for skin containing the components (a) to (c) of the present technology can be obtained by a known production method.
Specifically, as cosmetics or skin external preparations of this technology, for example, basic cosmetics such as milky lotion, cream, lotion, beauty liquid, pack, all-in-one gel, sunscreen, cleaning agent, makeup base, BB cream, etc. Any form such as foundation, make-up cosmetics such as cheeks and lipsticks, hair nourishers, hair tonics, shampoos, hair cosmetics such as rinses, dispersions, ointments, liquids, aerosols, patches, poultices, liniments, etc. It may be. Cosmetics or external preparations used on the skin that are expected to have a whitening effect, an emollient effect, and the like are preferable.
また、本技術の成分(c)を含む変色抑制剤は、公知の製法によって得ることができる。
本技術の変色抑制剤又は変色抑制方法の用途として、化粧料;医薬部外品、医薬品等の皮膚外用剤;経口剤、注射剤等に使用することも可能であり、特に、皮膚に適用するような、化粧料又は皮膚外用剤に使用することが好適である。
また、本技術の変色抑制剤を配合する形態としては、例えば、化粧料や医薬部外品、医薬品等の皮膚外用剤等が挙げられる。本技術の変色抑制剤をこれら形態に配合する際には、適宜許容される成分を含有させてもよい。また、本技術の変色抑制剤は、これらを製造するときに含有させることもできる。
Further, the discoloration inhibitor containing the component (c) of the present technology can be obtained by a known production method.
As an application of the discoloration inhibitor or discoloration suppression method of the present technology, it can also be used for cosmetics; quasi-drugs, external preparations for skin such as pharmaceuticals; oral preparations, injections, etc., and is particularly applied to the skin. It is suitable to be used for cosmetics or external preparations for skin.
In addition, examples of the form in which the discoloration inhibitor of the present technology is blended include cosmetics, quasi-drugs, and external preparations for skin such as pharmaceuticals. When the discoloration inhibitor of the present technology is blended in these forms, an appropriately acceptable component may be contained. Further, the discoloration inhibitor of the present technology can also be contained when these are produced.
以下、実施例、試験例等を挙げ、本発明(本技術)をさらに具体的に説明するが、本発明(本技術)はこれら実施例等に何ら制約されるものではない。 Hereinafter, the present invention (the present technology) will be described in more detail with reference to Examples, Test Examples and the like, but the present invention (the present technology) is not limited to these Examples and the like.
<試料調製>
リノール酸として、市販品(和光純薬工業社製)を購入し、遊離脂肪酸のリノール酸を使用した。
ビタミンEとして、市販品(エーザイ社製)を購入し、天然由来ビタミンE(植物由来)を使用した。当該市販品は、植物由来のビタミンEであり、少なくともα―トコフェロール、γ―トコフェロール及びδ―トコフェロールを含んでいる。
各植物抽出物は、以下のハトムギ抽出物、ローズマリー抽出物、シャクヤク抽出物、緑茶抽出物を使用した。
<Sample preparation>
As linoleic acid, a commercially available product (manufactured by Wako Pure Chemical Industries, Ltd.) was purchased, and the free fatty acid linoleic acid was used.
As vitamin E, a commercially available product (manufactured by Eisai Co., Ltd.) was purchased, and naturally-derived vitamin E (plant-derived) was used. The commercial product is plant-derived vitamin E and contains at least α-tocopherol, γ-tocopherol and δ-tocopherol.
For each plant extract, the following Coix seed extract, rosemary extract, peony extract, and green tea extract were used.
<製造例1.ハトムギ抽出物の調製>
イネ科(Poaceae)ジュズダマ属(Coix)ハトムギ(Coix lacryma-jobi var. ma-yuen)の種皮を除いた種子(ヨクイニン)の粉砕物10gに、80体積%エタノール水溶液(EtOH 8:水 2(Vol/Vol))200mLを加えて室温(10〜30℃)で3日間抽出を行なった後、抽出液を濾過後、溶媒を留去して乾固し、エキス純分としてハトムギ抽出物を得た。
<Manufacturing example 1. Preparation of Coix seed extract>
80% by volume ethanol aqueous solution (EtOH 8: water 2 (Vol / Vol)) 200 mL was added and extraction was performed at room temperature (10 to 30 ° C.) for 3 days. After filtering the extract, the solvent was distilled off and dried to obtain an Coix seed extract as pure extract. ..
<製造例2.ローズマリー抽出物の調製>
シソ科マンネンロウ属ローズマリー(学名:Rosmalinus Officinallis)の乾燥した葉10gに50体積%1,3−ブチレングリコール水溶液100mLを加えて室温(10〜30℃)で7日間抽出を行った後、ろ液を約5℃で7日間静置して熟成させた後、濾過した。濾液の溶媒を留去して乾固し、エキス純分としてローズマリー抽出物を得た。
<製造例3.シャクヤク抽出物の調製>
ボタン科ボタン属シャクヤク(学名:Paeonia lactiflora)の根10gを細切し、これに50体積%1,3−ブチレングリコール水溶液100mLを加えて加温(約50〜70℃)しながら撹拌し4時間抽出した後、濾過した。ろ液を約5℃で7日間静置して熟成させた後、濾過した。濾液の溶媒を留去して乾固し、エキス純分としてシャクヤク抽出物を得た。
<製造例4.緑茶植物抽出物の調製>
ツバキ科ツバキ属チャノキ(学名:Camellia Sinensis)の乾燥した葉10gを細切し、50体積%エタノール水溶液200mLを加えて室温(10〜30℃)で撹拌しながら2日間抽出を行った後、抽出液を濾過後、溶媒を留去して乾固し、エキス純分として緑茶抽出物を得た。
<Manufacturing example 2. Preparation of rosemary extract>
Add 100 mL of 50% by volume 1,3-butylene glycol aqueous solution to 10 g of dried leaves of Rosemary (Scientific name: Rosmarinus Officinallis) of the Labiatae family, and extract at room temperature (10 to 30 ° C.) for 7 days. Was allowed to stand at about 5 ° C. for 7 days for aging and then filtered. The solvent of the filtrate was distilled off and dried to obtain a rosemary extract as a pure extract.
<Manufacturing example 3. Preparation of peony extract>
10 g of roots of Peony peony (scientific name: Paeonia lactiflora) of Peony family are chopped, 100 mL of 50% by volume 1,3-butylene glycol aqueous solution is added thereto, and the mixture is stirred while heating (about 50 to 70 ° C) for 4 hours. After extraction, it was filtered. The filtrate was allowed to stand at about 5 ° C. for 7 days for aging and then filtered. The solvent of the filtrate was distilled off and dried to obtain a peony extract as a pure extract.
<Manufacturing example 4. Preparation of green tea plant extract>
10 g of dried leaves of Camellia genus Camellia (scientific name: Camellia Sinensis) are chopped, 200 mL of 50% by volume ethanol aqueous solution is added, and extraction is performed for 2 days while stirring at room temperature (10 to 30 ° C.), and then extracted. After filtering the liquid, the solvent was distilled off and the mixture was dried to obtain a green tea extract as a pure extract.
<色差測定方法>
50℃用及び5℃用の試料を入れるガラス瓶を準備した。試料をそれぞれのガラス瓶に分注し、ガラス瓶内の空気を置換せずにそのままの状態で、蓋をした。試料入りガラス瓶を、それぞれ50℃及び5℃の恒温器に入れて、一定期間静置した。
一定期間静置した各試料を測定用ガラスセルに移し、日本電色色差計SE−2000を用いてL*,a*,b*値を測色し、測色値から、ΔL=L*(5℃)—L*(50℃)、Δa=a*(5℃)—a*(50℃)、Δb=b*(5℃)—b*(50℃)を算出した。
次に以下の式に従いΔEを算出して、ΔEの値によって試料の変色を評価した。
ΔE=((ΔL)2+(Δa)2+(Δb)2)1/2
L*は「明度指数」(L軸=0〜100)、a*とb*は「クロマティクネス指数」(a軸=−120〜+120、b軸=−120〜+120)
<Color difference measurement method>
Glass bottles containing samples for 50 ° C and 5 ° C were prepared. The sample was dispensed into each glass bottle and covered as it was without replacing the air in the glass bottle. The glass bottles containing the samples were placed in incubators at 50 ° C. and 5 ° C., respectively, and allowed to stand for a certain period of time.
Transfer each sample that has been allowed to stand for a certain period of time to a glass cell for measurement, measure the L *, a *, and b * values using the Nippon Denshoku Color Difference Meter SE-2000, and from the color measurement value, ΔL = L * ( 5 ° C) — L * (50 ° C), Δa = a * (5 ° C) — a * (50 ° C), Δb = b * (5 ° C) — b * (50 ° C) ) Was calculated.
Next, ΔE was calculated according to the following formula, and the discoloration of the sample was evaluated by the value of ΔE.
ΔE = ((ΔL) 2 + (Δa) 2 + (Δb) 2 ) 1/2
L * is the "brightness index" (L axis = 0 to 100), and a * and b * are the "cromartie index" (a axis = -120 to +120, b axis = -120 to +120).
<試験例1:経時的安定性(変色)試験>
表1に示す各成分を混合して、試験例1〜3の試料を作製した。製造時の試料のpH(20℃)は6.5でこの試験例1〜3の試料を、上記色差測定方法にて測定を行い、4日間静置した後の5℃保管品と50℃保管品との色差ΔEを求めた。
<Test Example 1: Stability (discoloration) test over time>
Samples of Test Examples 1 to 3 were prepared by mixing each component shown in Table 1. The pH (20 ° C) of the sample at the time of manufacture was 6.5, and the samples of Test Examples 1 to 3 were measured by the above color difference measuring method, and after standing for 4 days, stored at 5 ° C and stored at 50 ° C. The color difference ΔE from the product was determined.
リノール酸及び天然由来ビタミンEを併用していない、天然由来ビタミンE単独の試験例2試料及びリノール酸単独の試験例3試料では、色差が1未満であり変色は生じていなかった。しかし、リノール酸及び天然由来ビタミンEを併用した試験例1試料では、それぞれ試験例2試料及び試験例3試料と比較すると、色差ΔEが試験開始わずか4日目という短期間であっても4倍及び8倍以上であり、肉眼においてもわずかに変色(黄変)が確認できたことから、経時的に変色がさらに進行することが予想された。 In Test Example 2 sample of natural vitamin E alone and Test Example 3 sample of linoleic acid alone, which did not use linoleic acid and naturally derived vitamin E in combination, the color difference was less than 1 and no discoloration occurred. However, in Test Example 1 sample in which linoleic acid and naturally occurring vitamin E were used in combination, the color difference ΔE was quadrupled even in a short period of only 4 days after the start of the test, as compared with Test Example 2 sample and Test Example 3 sample, respectively. And 8 times or more, and slight discoloration (yellowing) was confirmed with the naked eye, so it was expected that the discoloration would further progress over time.
リノール酸及びビタミンEを配合することで、4日目においても相乗効果的に色差が大きくなったことは全くの意外であり、本発明者らはそのメカニズムについて検討しているが、このメカニズムは未だ不明であるが、多価不飽和脂肪酸及びビタミンE類に起因した変色と考えている。 It is completely surprising that the combination of linoleic acid and vitamin E increased the color difference synergistically even on the 4th day, and the present inventors are investigating the mechanism, but this mechanism is Although it is still unknown, it is considered to be discoloration caused by polyunsaturated fatty acids and vitamin Es.
しかしながら、化粧料や皮膚外用剤等の製品において、変色は好ましくないことであり、一方で、多価不飽和脂肪酸又はビタミンE類の何れかの含有量を減らすことも考えられるが、何れも化粧料又は皮膚外用剤ではよく使用される成分であり、これをできるだけ自由な含有量で使用したい。
そこで、多価不飽和脂肪酸及びビタミンE類の含有量を気にすることなく、これらを含む組成物の変色を抑制できる成分の探索が必要となった。
However, discoloration is not preferable in products such as cosmetics and external preparations for skin, and on the other hand, it is conceivable to reduce the content of either polyunsaturated fatty acids or vitamin Es, but both are cosmetics. It is an ingredient that is often used in products or external preparations for skin, and we want to use it in as much free content as possible.
Therefore, it is necessary to search for a component capable of suppressing discoloration of the composition containing these without worrying about the contents of polyunsaturated fatty acids and vitamin Es.
[実施例1:化粧水]
そこで、本発明者らは、表2に示すように、リノール酸及び天然由来ビタミンEを含有させた化粧水において、各種植物抽出物を配合し、その経時的変色を、32日間静置した後の5℃保管品と50℃保管品の色差ΔEを用いて評価した。製造時の化粧水のpH(20℃)は5.1であった。比較例2〜4として、ハトムギ抽出物の代わりにシャクヤク抽出物、ローズマリー抽出物及び緑茶抽出物を配合した化粧水を評価した。
[Example 1: Toner]
Therefore, as shown in Table 2, the present inventors mixed various plant extracts in a lotion containing linoleic acid and naturally-derived vitamin E, and allowed the discoloration over time for 32 days. The color difference ΔE between the product stored at 5 ° C. and the product stored at 50 ° C. was used for evaluation. The pH (20 ° C.) of the cosmetic water at the time of production was 5.1. As Comparative Examples 2 to 4, a lotion containing a peony extract, a rosemary extract and a green tea extract instead of the Coix seed extract was evaluated.
<50℃と5℃のΔEの評価>
6未満 〇:ほぼ変色なし
6以上7.5未満 △:変色あり
7.5以上 ×:変色強い
<Evaluation of ΔE at 50 ° C and 5 ° C>
Less than 6 〇: Almost no discoloration 6 or more and less than 7.5 Δ: With discoloration 7.5 or more ×: Strong discoloration
製造方法
1.成分(1)〜(4)および成分(10)〜(13)をあわせて均一に混合する
2.成分(5)〜(9)、(14)、(15)を均一に混合する。
3.1を撹拌しながら2を徐々に添加し、添加終了後5分間まで撹拌して、化粧水を得た。
Manufacturing method 1. 2. Mix components (1) to (4) and components (10) to (13) together and uniformly. Ingredients (5) to (9), (14) and (15) are uniformly mixed.
2 was gradually added while stirring 3.1, and the mixture was stirred for 5 minutes after the addition was completed to obtain a lotion.
実際の製品である化粧水においても、植物抽出物を添加していない比較例1品は、経時的に変色が生じ、化粧料や皮膚外用剤に重要である経時安定性が認められなかった。
そして、シャクヤク抽出物、ローズマリー抽出物及び緑茶抽出物の何れを化粧水に配合しても、これら植物抽出物を添加していない比較例1の化粧水と比較すると、かえって変色が強くなってしまった。これら植物抽出物は、抗酸化作用を有することでもよく知られているが、単に抗酸化作用を有する植物抽出物だけでは、この変色を抑制することができないと考えた。このため、変色抑制成分としての指標がないため、経験則的に導き出すしかないと考え、様々な成分で行った。
Even in the actual product, the lotion, the product of Comparative Example 1 to which the plant extract was not added was discolored with time, and the stability over time, which is important for cosmetics and external preparations for skin, was not observed.
Regardless of which of the peony extract, rosemary extract and green tea extract is blended in the lotion, the discoloration becomes stronger as compared with the lotion of Comparative Example 1 to which these plant extracts are not added. Oops. It is well known that these plant extracts have an antioxidant effect, but it was considered that this discoloration cannot be suppressed only by the plant extracts having an antioxidant effect. For this reason, since there is no index as a discoloration suppressing component, it is considered that there is no choice but to derive it empirically, and various components were used.
本発明者らは、偶然にも、ハトムギ抽出物において、リノール酸及び天然由来ビタミンEを含む組成物の変色を抑制することができることを見出した。しかも、色差評価では、変色がないかほとんどないレベルまで達しており、格別顕著な効果といえる。また、リノール酸及び天然由来ビタミンE以外の成分を含む実用品において、変色抑制効果が認められたため、化粧料、皮膚外用剤、その他組成物といった幅広い製品にも応用可能であると考える。 The present inventors have found that, by chance, in the Coix seed extract, discoloration of a composition containing linoleic acid and naturally occurring vitamin E can be suppressed. Moreover, in the color difference evaluation, it has reached a level where there is no or almost no discoloration, which can be said to be a particularly remarkable effect. In addition, since a discoloration-suppressing effect was observed in a practical product containing components other than linoleic acid and naturally-derived vitamin E, it is considered that it can be applied to a wide range of products such as cosmetics, external preparations for skin, and other compositions.
[実施例3:化粧水]
(製法)
A.下記成分(6)〜(12)を混合溶解する。
B.下記成分(1)〜(5)と(13)を混合溶解する。
C.前記BにAを加え混合し、化粧水を得た。
[Example 3: Toner]
(Manufacturing method)
A. The following components (6) to (12) are mixed and dissolved.
B. The following components (1) to (5) and (13) are mixed and dissolved.
C. A was added to B and mixed to obtain a lotion.
(成分) (%)
1 グリセリン 5.0
2 1,3−ブチレングリコール 5.0
3 乳酸 0.05
4 乳酸ナトリウム 0.1
5 ハトムギ抽出物 (注1) 0.001
6 ポリオキシエチレン(60モル)硬化ヒマシ油 1.2
7 ポリオキシエチレン(40モル)硬化ヒマシ油 0.5
8 エタノール 8.0
9 リノール酸 0.1
10 合成ビタミンE(注2) 0.001
11 パラオキシ安息香酸メチル 0.1
12 香料 0.1
13 精製水 残量
(注1)製造例1のハトムギ抽出物
(注2)ビタミンEエーザイ(エーザイフード・ケミカル株式会社)
(Ingredient) (%)
1 Glycerin 5.0
2 1,3-butylene glycol 5.0
3 Lactic acid 0.05
4 Sodium lactate 0.1
5 Coix seed extract (Note 1) 0.001
6 Polyoxyethylene (60 mol) hardened castor oil 1.2
7 Polyoxyethylene (40 mol) hardened castor oil 0.5
8 Ethanol 8.0
9 Linoleic acid 0.1
10 Synthetic Vitamin E (Note 2) 0.001
11 Methyl paraoxybenzoate 0.1
12 Fragrance 0.1
13 Remaining amount of purified water (Note 1) Coix seed extract from Production Example 1 (Note 2) Vitamin E Eisai (Eisai Food & Chemical Co., Ltd.)
実施例3の化粧水は変色がなく経時安定性が良好であった。 The lotion of Example 3 had no discoloration and had good stability over time.
[実施例4:水中油乳化型化粧水]
(製造方法)
A:成分(1)〜(6)を70℃に加熱溶解する。
B:成分(7)〜(9)を70℃に加熱溶解後、前記Aに添加し乳化する。
C:前記Bを室温まで冷却する。
D:前記Cをマイクロフルイダイザーにて高圧処理(処理圧200)する。
E:前記Dに成分(10)〜(15)を均一に混合して水中油乳化型化粧水を得た。
[Example 4: Oil-in-water emulsified lotion]
(Production method)
A: Ingredients (1) to (6) are heated and dissolved at 70 ° C.
B: Ingredients (7) to (9) are heated and dissolved at 70 ° C., and then added to A for emulsification.
C: The B is cooled to room temperature.
D: The C is subjected to high pressure treatment (processing pressure 200) with a microfluidizer.
E: Ingredients (10) to (15) were uniformly mixed with D to obtain an oil-in-water emulsified lotion.
(成分) (%)
1 リノール酸 0.0001
2 水素添加大豆リン脂質 2
3 コレステロール 0.8
4 イソステアリン酸 3
5 天然ビタミンE(注3) 0.1
6 テトラ−2エチルヘキサン酸ペンタエリスリチル 1
7 グリセリン 8
8 ジプロピレングリコール 8
9 精製水 残量
10 ハトムギ抽出物(注4) 0.01
11 グリコシルトレハロース 5
12 ピロリドンカルボン酸ナトリウム 1
13 エタノール 5
14 パラオキシ安息香酸メチル 0.2
15 香料 0.2
(注3)イーミックス70L(エーザイフード・ケミカル社製)
(注4)イネ科(Poaceae)ジュズダマ属(Coix)ハトムギ(Coix lacryma-jobi var. ma-yuen)の種皮を除いた種子(ヨクイニン)の粉砕物10gに、50体積%1,3−ブチレングリコール水溶液(1,3−ブチレングリコール 1:水 1(Vol/Vol))1000mLを加えて室温(10〜30℃)で5日間抽出を行なった後、抽出液を濾過後、溶媒を留去してハトムギ抽出物を得て使用した。
(Ingredient) (%)
1 Linoleic acid 0.0001
2 Hydrogenated soybean phospholipids 2
3 Cholesterol 0.8
4 isostearic acid 3
5 Natural Vitamin E (Note 3) 0.1
6 Pentaerythrityl tetra-2 ethylhexanoate 1
7 glycerin 8
8 Dipropylene glycol 8
9 Purified water remaining amount 10 Coix seed extract (Note 4) 0.01
11 Glycosyl trehalose 5
12 Sodium pyrrolidone carboxylate 1
13 Ethanol 5
14 Methyl paraoxybenzoate 0.2
15 Fragrance 0.2
(Note 3) Emix 70L (manufactured by Eisai Food & Chemical Co., Ltd.)
(Note 4) 50% by volume 1,3-butylene glycol in 10 g of crushed seeds (Yokuinin) excluding the seed coat of Poaceae, Coix, and Coix lacryma-jobi var. Ma-yuen. After adding 1000 mL of an aqueous solution (1,3-butylene glycol 1: water 1 (Vol / Vol)) and extracting at room temperature (10 to 30 ° C.) for 5 days, the extract is filtered and the solvent is distilled off. Coix extract was obtained and used.
実施例4の化粧水は変色がなく経時安定性が良好であった。 The lotion of Example 4 had no discoloration and had good stability over time.
[実施例5:美容液]
(製法)
A.下記成分(1)〜(10)を混合溶解する。
B.下記成分(11)〜(17)を混合溶解する。
C.前記AにBを加え混合し、美容液を得た。
[Example 5: Essence]
(Manufacturing method)
A. The following components (1) to (10) are mixed and dissolved.
B. The following components (11) to (17) are mixed and dissolved.
C. B was added to A and mixed to obtain a beauty essence.
(成分) (%)
1 ジプロピレングリコール 5.0
2 1,3−ブチレングリコール 8.0
3 アクリル酸・メタクリル酸アルキル(C10−30)
クロスポリマー(注5) 0.2
4 キサンタンガム 0.2
5 精製水 残量
6 水酸化ナトリウム2%溶液 2.0
7 ハトムギ抽出物(注6) 0.005
8 ヒアルロン酸ナトリウム 0.01
9 加水分解エラスチン 0.01
10 加水分解コラーゲン 0.1
11 ポリオキシエチレン(60モル)硬化ヒマシ油 0.5
12 イソステアリン酸 0.2
13 リノール酸 0.001
14 天然由来ビタミンE(注3) 0.01
15 パラオキシ安息香酸メチル 0.1
16 エタノール 2.0
17 香料 0.02
(注5)CARBOPOL1382(LUBRIZOL社製)
(注6)イネ科(Poaceae)ジュズダマ属(Coix)ハトムギ(Coix lacryma-jobi var. ma-yuen)の種皮を除いた種子(ヨクイニン)の粉砕物10gに精製水400mLを加えて加温(50〜60℃)しながら撹拌し4時間抽出を行なった後、抽出液を濾過後、溶媒を留去してハトムギ抽出物を得て使用した。
(Ingredient) (%)
1 Dipropylene glycol 5.0
2 1,3-butylene glycol 8.0
3 Acrylic acid / alkyl methacrylate (C10-30)
Cross polymer (Note 5) 0.2
4 Xanthan gum 0.2
5 Remaining amount of purified water 6 Sodium hydroxide 2% solution 2.0
7 Coix seed extract (Note 6) 0.005
8 Sodium hyaluronate 0.01
9 Hydrolyzed elastin 0.01
10 Hydrolyzed collagen 0.1
11 Polyoxyethylene (60 mol) hardened castor oil 0.5
12 isostearic acid 0.2
13 Linoleic acid 0.001
14 Naturally-derived vitamin E (Note 3) 0.01
15 Methyl paraoxybenzoate 0.1
16 Ethanol 2.0
17 Fragrance 0.02
(Note 5) CARBOPOL 1382 (manufactured by LUBRIZOL)
(Note 6) Add 400 mL of purified water to 10 g of crushed seeds (Yokuinin) excluding the seed coat of Poaceae, Coix, and Coix lacryma-jobi var. Ma-yuen, and heat them (50). After stirring for 4 hours while stirring (~ 60 ° C.), the extract was filtered, and the solvent was distilled off to obtain an Coix extract for use.
実施例5の美容液は変色がなく経時安定性が良好であった。 The beauty essence of Example 5 had no discoloration and had good stability over time.
[実施例6:美容液]
(製造方法)
A:成分(1)〜(6)を70℃にて加熱溶解する。
B:成分(7)〜(19)を70℃にて加熱後、前記Aを添加して乳化し室温まで冷却して、水中油型美容液をえた。
[Example 6: Beauty essence]
(Production method)
A: Ingredients (1) to (6) are heated and dissolved at 70 ° C.
B: After heating the components (7) to (19) at 70 ° C., the above A was added and emulsified and cooled to room temperature to obtain an oil-in-water beauty essence.
(成分) (%)
1.リノール酸 0.1
2.セラミド3(注7) 0.1
3.トリエチルヘキサン酸グリセリル 3.0
4.セスキオレイン酸ソルビタン 1.5
5.ジメチルポリシロキサン(注8) 2.0
6.dl−α−トコフェロール(注9) 0.02
7.グリセリン 3.0
8.1,3−ブチレングリコール 5.0
9.1,2−ペンタンジオール 2.0
10.キサンタンガム 0.05
11.精製水 残量
12.リン酸 0.1
13.リン酸一水素ナトリウム 0.1
14.ハトムギ抽出物(注10) 0.00001
15.カルボキシメチルセルロース 2.0
16.キサンタンガム 0.1
17.ヒアルロン酸ナトリウム 0.05
18.エデト酸2ナトリウム 0.02
19.香料 0.5
(注7)CERAMIDE3(日光ケミカルズ社製)
(注8)KF-96-10CS(信越化学工業社製)
(注9)DSMニュートリションジャパン株式会社製
(注10)イネ科(Poaceae)ジュズダマ属(Coix)ハトムギ(Coix lacryma-jobi var. ma-yuen)の種子の粉砕物10gに、50体積%エタノール水溶液(EtOH 1:水 1(Vol/Vol))200mLを加えて室温(10〜30℃)で5日間抽出を行なった後、抽出液を濾過後、溶媒を留去してハトムギ抽出物を得た。
(Ingredient) (%)
1. 1. Linoleic acid 0.1
2. Ceramide 3 (Note 7) 0.1
3. 3. Glyceryl triethylhexanoate 3.0
4. Sorbitan sesquioleate 1.5
5. Dimethylpolysiloxane (Note 8) 2.0
6. dl-α-tocopherol (Note 9) 0.02
7. Glycerin 3.0
8.1,3-butylene glycol 5.0
9.1,2-Pentanediol 2.0
10. Xanthan gum 0.05
11. Remaining amount of purified water 12. Phosphoric acid 0.1
13. Sodium monohydrogen phosphate 0.1
14. Coix seed extract (Note 10) 0.00001
15. Carboxymethyl cellulose 2.0
16. Xanthan gum 0.1
17. Sodium hyaluronate 0.05
18. Disodium edetate 0.02
19. Fragrance 0.5
(Note 7) CERAMIDE3 (manufactured by Nikko Chemicals Co., Ltd.)
(Note 8) KF-96-10CS (manufactured by Shin-Etsu Chemical Co., Ltd.)
(Note 9) Made by DSM Nutrition Japan Co., Ltd. (Note 10) 10 g of crushed seeds of Poaceae, Coix, Coix lacryma-jobi var. Ma-yuen, and 50% by volume ethanol aqueous solution (Note 10) EtOH 1: 200 mL of water 1 (Vol / Vol) was added and extraction was performed at room temperature (10 to 30 ° C.) for 5 days, the extract was filtered, and the solvent was distilled off to obtain an Coix extract.
実施例6の美容液は変色がなく経時安定性が良好であった。 The beauty essence of Example 6 had no discoloration and had good stability over time.
[実施例7:水中油型乳液]
(製法)
A.成分(1)〜(5)を70℃で均一に溶解混合する。
B.成分(6)〜(14)を80℃で均一に溶解混合する。
C.前記AにBを添加し70℃で乳化する。
D.前記Cに成分(15)〜(19)を添加混合した後、40℃まで冷却して水中油型乳液を得た。
[Example 7: Oil-in-water emulsion]
(Manufacturing method)
A. Ingredients (1) to (5) are uniformly dissolved and mixed at 70 ° C.
B. The components (6) to (14) are uniformly dissolved and mixed at 80 ° C.
C. B is added to A and emulsified at 70 ° C.
D. After the components (15) to (19) were added to and mixed with C, the mixture was cooled to 40 ° C. to obtain an oil-in-water emulsion.
(成分) (%)
1 1,3−ブチレングリコール 5.0
2 ジブチレングリコール 5.0
3 精製水 残量
4 ハトムギ抽出物(注11) 0.5
5 水酸化ナトリウム2%溶液 0.2
6 N−ミリストイル−L−グルタミン酸 0.2
7 ポリオキシエチレン(10モル)硬化ヒマシ油 0.2
8 マカデミアナッツ油脂肪酸フィトステリル 1.0
9 トリ(カプリル酸/カプリル酸)グリセリル 0.2
10 リノール酸 0.1
11 天然ビタミンE(注3) 1
12 N−ステアロイルフィトスフィンゴシン 0.1
13 酢酸トコフェロール 0.01
14 ステアリルアルコール 0.5
15 1,2−ペンタンジオール 0.1
16 カルボキシビニルポリマー(注12) 0.15
17 (アクリル酸Na/アクリロイルジメチルタウリンNa)
コポリマー(注13) 2
18 エタノール 5.0
19 香料 0.1
(注11)イネ科(Poaceae)ジュズダマ属(Coix)ハトムギ(Coix lacryma-jobi var. ma-yuen)の葉の粉砕物10gに、50体積%エタノール水溶液(EtOH 1:水 1(Vol/Vol))200mLを加えて室温(10〜30℃)で5日間抽出を行なった後、抽出液を濾過後、溶媒を留去してハトムギ抽出物を得た。
(注12) CARBOPO941(LUBRIZOL ADVANNCED MATERIALS社製)
(注13) SIMULGEL EG(SEPIC社製)
(Ingredient) (%)
1 1,3-butylene glycol 5.0
2 Dibutylene glycol 5.0
3 Remaining amount of purified water 4 Coix seed extract (Note 11) 0.5
5 Sodium hydroxide 2% solution 0.2
6 N-myristoylation-L-glutamic acid 0.2
7 Polyoxyethylene (10 mol) hardened castor oil 0.2
8 Macadamia nut oil fatty acid phytosteryl 1.0
9 Tri (caprylic acid / caprylic acid) glyceryl 0.2
10 Linoleic acid 0.1
11 Natural Vitamin E (Note 3) 1
12 N-stearoyl phytosphingosine 0.1
13 Tocopherol acetate 0.01
14 Stearyl alcohol 0.5
15 1,2-pentanediol 0.1
16 Carboxyvinyl polymer (Note 12) 0.15
17 (Na acrylate / Na acryloyl dimethyl taurine)
Copolymer (Note 13) 2
18 Ethanol 5.0
19 Fragrance 0.1
(Note 11) 50% by volume ethanol aqueous solution (EtOH 1: water 1 (Vol / Vol)) in 10 g of crushed leaves of Poaceae, Coix, and Coix lacryma-jobi var. Ma-yuen. ) 200 mL was added and extraction was performed at room temperature (10 to 30 ° C.) for 5 days, the extract was filtered, and the solvent was distilled off to obtain an Coix seed extract.
(Note 12) CARBOPO941 (manufactured by LUBRIZOL ADVANNCED MATERIALS)
(Note 13) SIMULGEL EG (manufactured by SEPIC)
実施例7の乳液は変色がなく経時安定性が良好であった。 The emulsion of Example 7 had no discoloration and had good stability over time.
[実施例8:乳液]
(製法)
A:成分(1)〜(8)を70℃にて加熱溶解する。
B:成分(9)〜(15)を70℃にて加熱後、前記Aに添加し乳化する。
C:前記Bを室温まで冷却後、成分(16)〜(18)を添加し、水中油型美容液
を得た。
[Example 8: Emulsion]
(Manufacturing method)
A: Ingredients (1) to (8) are heated and dissolved at 70 ° C.
B: Ingredients (9) to (15) are heated at 70 ° C. and then added to A for emulsification.
C: After cooling the B to room temperature, the components (16) to (18) were added to obtain an oil-in-water beauty essence.
(成分) (%)
1.リノール酸 0.6
2.α−リノレン酸(注14) 0.4
3.水素添加大豆リン脂質 1.2
4.δ―トコフェロール(注15) 0.003
5.α―トコフェロール(注16) 0.002
6.1,3−ブチレングリコール 16.0
7.イソノナン酸イソトリデシル 1.0
8.トリエチルヘキサノイン 1.0
9.精製水 残量
10.クエン酸 0.1
11.クエン酸ナトリウム 0.1
12.水酸化ナトリウム 適量
13.ハトムギ抽出物(注17) 0.0001
14.ヒドロキシプロリン 0.01
15.フェノキシエタノール 0.5
16.エタノール 8
17.カルボキシビニルポリマー(注12) 0.2
18.キサンタンガム 0.2
(注14)和光純薬社製
(注15)シグマ・アルドリッチ社製
(注16)シグマ・アルドリッチ社製
(注17)イネ科(Poaceae)ジュズダマ属(Coix)ハトムギ(Coix lacryma-jobi var. ma-yuen)の種子の粉砕物10gに、100%エタノール100mLを加えて室温(10〜30℃)で2日間抽出を行なった後、抽出液を濾過後、溶媒を留去してハトムギ抽出物を得た。
(Ingredient) (%)
1. 1. Linoleic acid 0.6
2. α-linolenic acid (Note 14) 0.4
3. 3. Hydrogenated soybean phospholipid 1.2
4. δ-tocopherol (Note 15) 0.003
5. α-tocopherol (Note 16) 0.002
6.1,3-butylene glycol 16.0
7. Isotridecyl isononanoate 1.0
8. Triethylhexanoin 1.0
9. Remaining amount of purified water 10. Citric acid 0.1
11. Sodium citrate 0.1
12. Appropriate amount of sodium hydroxide 13. Coix seed extract (Note 17) 0.0001
14. Hydroxyproline 0.01
15. Phenoxyethanol 0.5
16. Ethanol 8
17. Carboxyvinyl polymer (Note 12) 0.2
18. Xanthan gum 0.2
(Note 14) Wako Junyaku Co., Ltd. (Note 15) Sigma Aldrich Co., Ltd. (Note 16) Sigma Aldrich Co., Ltd. (Note 17) Gramineae (Poaceae) Coix Coix Coix lacryma-jobi var. Ma -Yuen) 100 mL of 100% ethanol was added to 10 g of crushed seeds and extracted at room temperature (10 to 30 ° C.) for 2 days. After filtering the extract, the solvent was distilled off to obtain the Coix extract. Obtained.
実施例8の乳液は変色が少なく経時安定性が良好であった。 The emulsion of Example 8 had little discoloration and good stability over time.
[実施例9:クリーム]
(製法)
A:成分(1)〜(10)を70℃にて加熱溶解する。
B:成分(11)〜(17)を70℃にて加熱後、前記Aを添加し乳化する。
C:前記Bを室温まで冷却し、(18)〜(20)を添加混合して水中油型クリームをえた。
[Example 9: Cream]
(Manufacturing method)
A: Ingredients (1) to (10) are heated and dissolved at 70 ° C.
B: After heating the components (11) to (17) at 70 ° C., the above A is added and emulsified.
C: The B was cooled to room temperature, and (18) to (20) were added and mixed to obtain an oil-in-water cream.
(成分) (%)
1.リノール酸 1
2.ドコサヘキサエン酸(DHA)(注18) 1
3.モノオレイン酸ポリオキシエチレン(20)ソルビタン 2.0
4.ポリオキシエチレンアルキルエーテルリン酸 (注19) 0.3
5.ジカプリン酸プロピレングリコール 1.7
6.スクワラン 3.5
7.セトステアリルアルコール 3.0
8.ワセリン 2.0
9.ホホバ油 1.0
10.合成型ビタミンE(注2) 3
11.1,3−ブチレングリコール 2.0
12.グリセリン 10.0
13.カルボキシビニルポリマー (注20) 0.3
14.カラギーナン 0.1
15.水酸化ナトリウム 適量
16.精製水 残量
17.ハトムギ抽出物(注1) 1
18.パラオキシ安息香酸メチル 0.3
19.エタノール 7
20.香料 0.2
(注1)製造例1のハトムギ抽出物
(注18)和光純薬社製
(注19)NIKKOL-DDP10(日光ケミカルズ社製)
(注20)ハイビスワコー105(和光純薬工業社製)
(Ingredient) (%)
1. 1. Linoleic acid 1
2. Docosahexaenoic acid (DHA) (Note 18) 1
3. 3. Polyoxyethylene monooleate (20) Sorbitan 2.0
4. Polyoxyethylene alkyl ether phosphoric acid (Note 19) 0.3
5. Propylene Glycol Dicaprate 1.7
6. Squalene 3.5
7. Setostearyl alcohol 3.0
8. Vaseline 2.0
9. Jojoba oil 1.0
10. Synthetic vitamin E (Note 2) 3
11.1, 3-butylene glycol 2.0
12. Glycerin 10.0
13. Carboxyvinyl polymer (Note 20) 0.3
14. Carrageenan 0.1
15. Appropriate amount of sodium hydroxide 16. Remaining amount of purified water 17. Coix seed extract (Note 1) 1
18. Methyl paraoxybenzoate 0.3
19. Ethanol 7
20. Fragrance 0.2
(Note 1) Coix seed extract of Production Example 1 (Note 18) manufactured by Wako Pure Chemical Industries, Ltd. (Note 19) NIKKOL-DDP10 (manufactured by Nikko Chemicals Co., Ltd.)
(Note 20) Hibiswaco 105 (manufactured by Wako Pure Chemical Industries, Ltd.)
実施例9のクリームは変色が少なく経時安定性が良好であった。 The cream of Example 9 had little discoloration and good stability over time.
[実施例10:日焼け止め料]
(製法)
A.成分(10)〜(12)を三本ロールにて分散処理する。
B.前記Aと、成分(1)〜(9)を70℃に加温する。
C.成分(13)〜(18)を70℃に加温する。
D.前記CにBを加え、乳化する。
E.前記Dを室温まで冷却して冷却してクリーム状水中油乳化型乳日焼け止め料を得た。
[Example 10: Sunscreen charge]
(Manufacturing method)
A. The components (10) to (12) are dispersed in three rolls.
B. The A and the components (1) to (9) are heated to 70 ° C.
C. Ingredients (13) to (18) are heated to 70 ° C.
D. B is added to C and emulsified.
E. The D was cooled to room temperature and cooled to obtain a creamy oil-in-water emulsified milk sunscreen.
(成分) (%)
1.セトステアリルアルコール 1
2.流動パラフィン 3
3.モノオレイン酸ポリオキシエチレン(20)ソルビタン 2
4.ポリオキシエチレン(60モル)硬化ヒマシ油 1
5.ポリオキシエチレンアルキルエーテルリン酸 (注19) 0.1
6.アクリル−シリコーン系グラフト共重合体溶液 (注21) 1
7.パラメトキシケイ皮酸オクチル 10
8.天然ビタミンE(注3) 0.001
9.リノール酸 0.05
10.ミリスチン酸(3%)メチルハイドロジェンポリシロキサン
(15%)処理酸化亜鉛(粒子径20nm) 10
11.デカメチルシクロペンタシロキサン 15
12.(ジメチコン/フェニルジメチコン)クロスポリマー混合物
(固形分15%) (注22) 10
13.ステアロイルメチルタウリンナトリウム 2.0
14.(アクリル酸ナトリウム/アクリロイルジメチルタウリン
ナトリウム)コポリマー (注23) 4
15.1,3−ブチレングリコール 8
16.ポリエチレングリコール (注24) 5
17.精製水 残量
18.ハトムギ抽出物(注1) 0.4
(注1)製造例1のハトムギ抽出物
(注21)KP545L(信越化学工業社製)
(注22)KSG−18(信越化学工業社製)
(注23)SIMULGEL EG1(本質分37.5% SEPPIC社製)
(注24)PEG400(三洋化成工業社製)
(Ingredient) (%)
1. 1. Setostearyl alcohol 1
2. Liquid paraffin 3
3. 3. Polyoxyethylene monooleate (20) Sorbitan 2
4. Polyoxyethylene (60 mol) hardened castor oil 1
5. Polyoxyethylene alkyl ether phosphoric acid (Note 19) 0.1
6. Acrylic-silicone graft copolymer solution (Note 21) 1
7. Octyl paramethoxycinnamic acid 10
8. Natural Vitamin E (Note 3) 0.001
9. Linoleic acid 0.05
10. Myristic acid (3%) Methylhydrogenpolysiloxane (15%) treated Zinc oxide (particle size 20 nm) 10
11. Decamethylcyclopentasiloxane 15
12. (Dimethicone / Phenyldimethicone) Crosspolymer mixture (solid content 15%) (Note 22) 10
13. Stearoyl Methyl Taurine Sodium 2.0
14. (Sodium acrylate / sodium acryloyldimethyltaurine) copolymer (Note 23) 4
15.1,3-butylene glycol 8
16. Polyethylene glycol (Note 24) 5
17. Remaining amount of purified water 18. Coix seed extract (Note 1) 0.4
(Note 1) Coix seed extract from Production Example 1 (Note 21) KP545L (manufactured by Shin-Etsu Chemical Co., Ltd.)
(Note 22) KSG-18 (manufactured by Shin-Etsu Chemical Co., Ltd.)
(Note 23) SIMULGEL EG1 (essential 37.5% manufactured by SEPPIC)
(Note 24) PEG400 (manufactured by Sanyo Chemical Industries, Ltd.)
実施例10の日焼け止め料は変色がなく経時安定性が良好であった。 The sunscreen of Example 10 had no discoloration and had good stability over time.
[実施例11:リキッドファンデーション]
(製法)
A:成分(15)〜(22)を3本ローラーにて分散処理する。
B:成分(1)〜(9)を90℃にて加熱し均一混合する。
C:前記Bに約90℃に加熱した(10)を添加し乳化後、冷却して(11)〜(14)を添加した。
D:前記CにAを混合する
E:前記Dを容器に充填して水中油型リキッドファンデーションをえた。
[Example 11: Liquid foundation]
(Manufacturing method)
A: The components (15) to (22) are dispersed by a three-roller.
B: Ingredients (1) to (9) are heated at 90 ° C. and uniformly mixed.
C: (10) heated to about 90 ° C. was added to the B, emulsified, cooled, and (11) to (14) were added.
D: A is mixed with C. E: The D is filled in a container to obtain an oil-in-water liquid foundation.
(成分) (%)
1.ポリオキシエチレン(60)硬化ヒマシ油 0.5
2.テトラオレイン酸ポリオキシエチレン(20)ソルビット 1
3.(ジメチコン/ビニルジメチコン)
クロスポリマー混合物(固形分5%)(注25) 10
4.メチルトリメチコン 5
5.メトキシケイ皮酸オクチル 3
6.ビスエチルヘキシルオキシフェノール
メトキシフェニルトリアジン(注26) 5
7.アクリル−シリコーン系グラフト共重合体溶液(注27) 5
8.リノール酸 0.1
9.天然ビタミンE(注3) 0.00001
10.精製水 残量
11.(アクリル酸ナトリウム/アクリロイルジメチルタウリン
ナトリウム)コポリマー(注19) 1
12.フェノキシエタノール 0.3
13.1,3ブチレングリコール 10
14.ハトムギ抽出物(注1) 0.0001
15.アクリル酸アルキルポリマーエマルション(注28) 3
16.トリエタノールアミン 3.5
17.黒酸化鉄 0.2
18.ベンガラ 1.3
19.酸化チタン 8
20.黄酸化鉄 0.5
21.セリサイト 5
22.赤色202号 0.2
(注1)製造例1のハトムギ抽出物
(注3)イーミックス70L(エーザイフード・ケミカル社製)
(注25)KSG-15(信越化学工業社製)
(注26)TINOSORB S(BASF社製)
(注27)KP-541(信越化学工業社製)
(注28)ウルトラゾールV-280C(アイカ工業社製)
(Ingredient) (%)
1. 1. Polyoxyethylene (60) hardened castor oil 0.5
2. Polyoxyethylene tetraoleate (20) sorbitol 1
3. 3. (Dimethicone / Vinyl Dimethicone)
Cross-polymer mixture (solid content 5%) (Note 25) 10
4. Methyltrimethicone 5
5. Octyl methoxycinnamic acid 3
6. Bisethylhexyloxyphenol Methoxyphenyltriazine (Note 26) 5
7. Acrylic-silicone graft copolymer solution (Note 27) 5
8. Linoleic acid 0.1
9. Natural Vitamin E (Note 3) 0.00001
10. Remaining amount of purified water 11. (Sodium Acrylate / Acryloyl Dimethyl Taurine Sodium) Copolymer (Note 19) 1
12. Phenoxyethanol 0.3
13.1,3 Butylene glycol 10
14. Coix seed extract (Note 1) 0.0001
15. Alkyl acrylate polymer emulsion (Note 28) 3
16. Triethanolamine 3.5
17. Black iron oxide 0.2
18. Bengala 1.3
19. Titanium oxide 8
20. Yellow iron oxide 0.5
21. Sericite 5
22. Red No. 202 0.2
(Note 1) Coix seed extract from Production Example 1 (Note 3) Emix 70L (manufactured by Eisai Food & Chemical Co., Ltd.)
(Note 25) KSG-15 (manufactured by Shin-Etsu Chemical Co., Ltd.)
(Note 26) TINOSORB S (manufactured by BASF)
(Note 27) KP-541 (manufactured by Shin-Etsu Chemical Co., Ltd.)
(Note 28) Ultrasol V-280C (manufactured by Aica Kogyo Co., Ltd.)
実施例11のリキッドファンデーションは変色がなく経時安定性が良好であった。 The liquid foundation of Example 11 had no discoloration and had good stability over time.
[実施例12:含侵マスク]
(製法)
A:成分(1)〜(6)を70℃に加熱溶解する。
B:成分(7)〜(11)を70℃に加熱溶解後、前記Aに添加し乳化する。
C:前記Bを室温まで冷却し(12)〜(14)を加えて混合し、水中油型乳液をえた。
D:前記Cを不織布にしみこませ、含侵マスクを得た
(成分) (%)
1.ジプロピレングリコール 10
2.ポリオキシエチレン(40)硬化ヒマシ油 0.5
3.パラオキシ安息香酸メチル 0.1
4.スクワラン 0.5
5.リノール酸 0.04
6.天然ビタミンE(注3) 0.01
7.グリセリン 10
8.精製水 残量
9.温泉水 1
10.水酸化ナトリウム 適量
11.ハトムギ抽出液(注1) 0.0001
12.カルボキシビニルポリマー(注20) 0.1
13.キサンタンガム 0.05
14.香料 0.2
(注1)製造例1のハトムギ抽出物
(注3)イーミックス70L(エーザイフード・ケミカル社製)
(注20)ハイビスワコー105(和光純薬工業社製)
[Example 12: Invasion mask]
(Manufacturing method)
A: Ingredients (1) to (6) are heated and dissolved at 70 ° C.
B: Ingredients (7) to (11) are heated and dissolved at 70 ° C., and then added to A for emulsification.
C: The B was cooled to room temperature, (12) to (14) were added and mixed to obtain an oil-in-water emulsion.
D: The C was impregnated into a non-woven fabric to obtain an impregnation mask (component) (%).
1. 1. Dipropylene glycol 10
2. Polyoxyethylene (40) hardened castor oil 0.5
3. 3. Methyl paraoxybenzoate 0.1
4. Squalene 0.5
5. Linoleic acid 0.04
6. Natural Vitamin E (Note 3) 0.01
7. Glycerin 10
8. Remaining amount of purified water 9. Hot spring water 1
10. Appropriate amount of sodium hydroxide 11. Coix seed extract (Note 1) 0.0001
12. Carboxyvinyl polymer (Note 20) 0.1
13. Xanthan gum 0.05
14. Fragrance 0.2
(Note 1) Coix seed extract from Production Example 1 (Note 3) Emix 70L (manufactured by Eisai Food & Chemical Co., Ltd.)
(Note 20) Hibiswaco 105 (manufactured by Wako Pure Chemical Industries, Ltd.)
実施例12の含浸マスクは変色がなく経時安定性が良好であった。 The impregnated mask of Example 12 had no discoloration and had good stability over time.
[実施例13:ハンドクリーム]
(製法)
A:成分(1)〜(12)、(24)を70℃で混合溶解する。
B:成分(13)〜(23)を70℃で混合溶解する
C:撹拌しながら前記BにAを加えて乳化する
D:前記Cを室温まで冷却しハンドクリームを得た。
[Example 13: Hand cream]
(Manufacturing method)
A: Ingredients (1) to (12) and (24) are mixed and dissolved at 70 ° C.
B: Ingredients (13) to (23) are mixed and dissolved at 70 ° C. C: A is added to B while stirring to emulsify D: C is cooled to room temperature to obtain a hand cream.
(成分) (%)
1.モノステアリン酸ポリエチレングリコール 2
2.モノステアリン酸グリセリン 3
3.セトステアリルアルコール 2
4.ベヘニルアルコール 3
5.流動パラフィン 4
6.ワセリン 10
7.ラウロイルグルタミン酸ジ(オクチルドデシル
/フィトステリル/ベヘニル)(注29) 2
8.オレイン酸オレイル 1
9.コエンザイムQ10 0.2
10.リノール酸 0.04
11.天然ビタミンE(注3) 0.01
12.パルミチン酸レチノール 0.3
13.パラオキシ安息香酸メチル 0.2
14.濃グリセリン 5
15.1.3.ブチレングリコール 10
16.リン酸1水素ナトリウム 0.1
17.リン酸2水素ナトリウム 0.1
18.エデト酸2ナトリウム 0.1
19.水酸化ナトリウム 適量
20.精製水 残量
21.ハトムギ抽出物(注1) 0.0001
22.ローヤルゼリー抽出液 0.1
23.アスコルビン酸リン酸マグネシウム 0.5
24.香料 0.2
(注1)製造例1のハトムギ抽出物
(注3)イーミックス70L(エーザイフード・ケミカル社製)
(注29)エルデュウPS-304(味の素社製)
(Ingredient) (%)
1. 1. Polyethylene glycol monostearate 2
2. Glycerin monostearate 3
3. 3. Setostearyl alcohol 2
4. Behenyl alcohol 3
5. Liquid paraffin 4
6. Vaseline 10
7. Di (octyldodecyl / phytosteryl / behenyl) lauroyl glutamate (Note 29) 2
8. Oleyl oleate 1
9. Coenzyme Q10 0.2
10. Linoleic acid 0.04
11. Natural Vitamin E (Note 3) 0.01
12. Retinol palmitate 0.3
13. Methyl paraoxybenzoate 0.2
14. Concentrated glycerin 5
15.1.3. Butylene glycol 10
16. Sodium monohydrogen phosphate 0.1
17. Sodium dihydrogen phosphate 0.1
18. Disodium edetate 0.1
19. Appropriate amount of sodium hydroxide 20. Remaining amount of purified water 21. Coix seed extract (Note 1) 0.0001
22. Royal jelly extract 0.1
23. Magnesium Ascorbic Acid Phosphate 0.5
24. Fragrance 0.2
(Note 1) Coix seed extract from Production Example 1 (Note 3) Emix 70L (manufactured by Eisai Food & Chemical Co., Ltd.)
(Note 29) Eldu PS-304 (manufactured by Ajinomoto Co., Inc.)
実施例13のハンドクリームは変色がなく経時安定性が良好であった。 The hand cream of Example 13 had no discoloration and had good stability over time.
[実施例14:化粧水]
(製法)
A.下記成分(6)〜(12)を混合溶解する。
B.下記成分(1)〜(5)と(13)を混合溶解する。
C.前記BにAを加え混合し、化粧水を得た。
[Example 14: Toner]
(Manufacturing method)
A. The following components (6) to (12) are mixed and dissolved.
B. The following components (1) to (5) and (13) are mixed and dissolved.
C. A was added to B and mixed to obtain a lotion.
(成分) (%)
1 グリセリン 5.0
2 1,3−ブチレングリコール 5.0
3 乳酸 0.05
4 乳酸ナトリウム 0.1
5 ハトムギ植物抽出物 (注1) 0.001
6 ポリオキシエチレン(60モル)硬化ヒマシ油 1.2
7 ポリオキシエチレン(40モル)硬化ヒマシ油 0.5
8 エタノール 8.0
9 α−リノレン酸(注14) 0.1
10 合成ビタミンE(注2) 0.001
11 パラオキシ安息香酸メチル 0.1
12 香料 0.1
13 精製水 残量
(注1)製造例1のハトムギ植物抽出物
(Ingredient) (%)
1 Glycerin 5.0
2 1,3-butylene glycol 5.0
3 Lactic acid 0.05
4 Sodium lactate 0.1
5 Coix plant extract (Note 1) 0.001
6 Polyoxyethylene (60 mol) hardened castor oil 1.2
7 Polyoxyethylene (40 mol) hardened castor oil 0.5
8 Ethanol 8.0
9 α-linolenic acid (Note 14) 0.1
10 Synthetic Vitamin E (Note 2) 0.001
11 Methyl paraoxybenzoate 0.1
12 Fragrance 0.1
13 Remaining amount of purified water (Note 1) Coix plant extract of Production Example 1
実施例14の化粧水は変色がなく経時安定性が良好であった。 The lotion of Example 14 had no discoloration and had good stability over time.
[実施例15:水中油型乳液]
(製法)
A.成分(1)〜(5)を70℃で均一に溶解混合する。
B.成分(6)〜(14)を80℃で均一に溶解混合する。
C.前記AにBを添加し70℃で乳化する。
D.前記Cに成分(15)〜(19)を添加混合した後、40℃まで冷却して水中油型乳液を得た。
[Example 15: Oil-in-water emulsion]
(Manufacturing method)
A. Ingredients (1) to (5) are uniformly dissolved and mixed at 70 ° C.
B. The components (6) to (14) are uniformly dissolved and mixed at 80 ° C.
C. B is added to A and emulsified at 70 ° C.
D. After the components (15) to (19) were added to and mixed with C, the mixture was cooled to 40 ° C. to obtain an oil-in-water emulsion.
(成分) (%)
1 1,3−ブチレングリコール 5.0
2 ジブチレングリコール 5.0
3 精製水 残量
4 ハトムギ植物抽出物(注11) 0.5
5 水酸化ナトリウム2%溶液 0.2
6 N−ミリストイル−L−グルタミン酸 0.2
7 ポリオキシエチレン(10モル)硬化ヒマシ油 0.2
8 マカデミアナッツ油脂肪酸フィトステリル 1.0
9 トリ(カプリル酸/カプリル酸)グリセリル 0.2
10 ドコサヘキサエン酸(DHA)(注18) 0.1
11 天然ビタミンE(注3) 1
12 N−ステアロイルフィトスフィンゴシン 0.1
13 酢酸トコフェロール 0.01
14 ステアリルアルコール 0.5
15 1,2−ペンタンジオール 0.1
16 カルボキシビニルポリマー(注12) 0.15
17 (アクリル酸Na/アクリロイルジメチルタウリンNa)
コポリマー(注13) 2
18 エタノール 5.0
19 香料 0.1
(注11)実施例7のハトムギ抽出物。
(Ingredient) (%)
1 1,3-butylene glycol 5.0
2 Dibutylene glycol 5.0
3 Remaining amount of purified water 4 Coix seed plant extract (Note 11) 0.5
5 Sodium hydroxide 2% solution 0.2
6 N-myristoylation-L-glutamic acid 0.2
7 Polyoxyethylene (10 mol) hardened castor oil 0.2
8 Macadamia nut oil fatty acid phytosteryl 1.0
9 Tri (caprylic acid / caprylic acid) glyceryl 0.2
10 Docosahexaenoic acid (DHA) (Note 18) 0.1
11 Natural Vitamin E (Note 3) 1
12 N-stearoyl phytosphingosine 0.1
13 Tocopherol acetate 0.01
14 Stearyl alcohol 0.5
15 1,2-pentanediol 0.1
16 Carboxyvinyl polymer (Note 12) 0.15
17 (Na acrylate / Na acryloyl dimethyl taurine)
Copolymer (Note 13) 2
18 Ethanol 5.0
19 Fragrance 0.1
(Note 11) Coix seed extract of Example 7.
実施例15の乳液は変色がなく経時安定性が良好であった。
The emulsion of Example 15 had no discoloration and had good stability over time.
Claims (6)
(a)炭素数16〜22の多価不飽和脂肪酸から選ばれる1種又は2種以上
(b)ビタミンE類から選ばれる1種又は2種以上
を含有する組成物の変色を抑制する剤。 The following components (a) and (b), which contain Coix seed extract as an active ingredient;
(A) One or more selected from polyunsaturated fatty acids having 16 to 22 carbon atoms (b) An agent that suppresses discoloration of a composition containing one or more selected from vitamin Es.
(a)炭素数16〜22の多価不飽和脂肪酸から選ばれる1種又は2種以上
(b)ビタミンE類から選ばれる1種又は2種以上
A method for suppressing discoloration of a composition containing the following component (a) and component (b) using Coix seed extract.
(A) One or more selected from polyunsaturated fatty acids having 16 to 22 carbon atoms (b) One or more selected from vitamin Es
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
JP2017069476A JP6930847B2 (en) | 2017-03-31 | 2017-03-31 | Cosmetics or topical skin agents |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
JP2017069476A JP6930847B2 (en) | 2017-03-31 | 2017-03-31 | Cosmetics or topical skin agents |
Publications (2)
Publication Number | Publication Date |
---|---|
JP2018172291A JP2018172291A (en) | 2018-11-08 |
JP6930847B2 true JP6930847B2 (en) | 2021-09-01 |
Family
ID=64108231
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
JP2017069476A Active JP6930847B2 (en) | 2017-03-31 | 2017-03-31 | Cosmetics or topical skin agents |
Country Status (1)
Country | Link |
---|---|
JP (1) | JP6930847B2 (en) |
Families Citing this family (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
KR102132469B1 (en) * | 2019-11-19 | 2020-07-09 | 심백만 | Composition for improving scalp and hair condition |
Family Cites Families (4)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
JP2953091B2 (en) * | 1991-01-24 | 1999-09-27 | 味の素株式会社 | Method of controlling oxidation of fats and oils |
JP2002003371A (en) * | 2000-06-21 | 2002-01-09 | Shiseido Co Ltd | STEROID 5alpha-REDUCTASE INHIBITOR, AND PHARMACEUTICAL COMPOSITION, COSMETIC COMPOSITION, HAIR TONIC AND SKIN DAMAGE TREATING AGENT CONTAINING THE INHIBITOR AS ACTIVE COMPONENT |
JP2003267854A (en) * | 2002-03-15 | 2003-09-25 | Kose Corp | Bleaching cosmetic |
JP3747192B2 (en) * | 2002-08-30 | 2006-02-22 | 株式会社コーセー | Topical skin preparation |
-
2017
- 2017-03-31 JP JP2017069476A patent/JP6930847B2/en active Active
Also Published As
Publication number | Publication date |
---|---|
JP2018172291A (en) | 2018-11-08 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
EP2727580B1 (en) | Astaxanthin-containing composition, method for manufacturing same, and cosmetic | |
EP1285661B1 (en) | Use of an antioxidant comprising an extract of mozuku | |
JP6930847B2 (en) | Cosmetics or topical skin agents | |
US8940312B2 (en) | Composition containing polyunsaturated fatty acid | |
JP6930846B2 (en) | Cosmetics or topical skin agents | |
JP2006151831A (en) | Antioxidant, dna damage inhibitor or skin care preparation | |
JP6930848B2 (en) | Cosmetics or topical skin agents | |
JP6930845B2 (en) | Cosmetics and external preparations for skin | |
JP6898137B2 (en) | Cosmetics or topical skin agents | |
JP7051494B2 (en) | Cosmetics and external skin preparations | |
JP7125268B2 (en) | Cosmetics and external skin preparations | |
JP7140509B2 (en) | How to control discoloration | |
JP7168330B2 (en) | Cosmetics and external skin preparations | |
JP7112208B2 (en) | Cosmetics and external skin preparations | |
JP7254447B2 (en) | Cosmetics and external skin preparations | |
JP7109860B2 (en) | Cosmetics and external skin preparations | |
JP7139034B2 (en) | Cosmetics and external skin preparations | |
JP2019131524A (en) | Cosmetic and skin external preparation | |
JP7166063B2 (en) | Cosmetics and external skin preparations | |
JP2006282536A (en) | Super oxide-eliminating agent, free radical-eliminating agent, hydrogen peroxide-eliminating agent and external preparation for skin | |
JP6399545B2 (en) | Anti-oxidant derived from microalgae and cosmetic or skin external preparation containing the same | |
JP2024096071A (en) | Cosmetics or topical skin preparations | |
JP2024096069A (en) | Cosmetics or topical skin preparations | |
JP2024096070A (en) | Cosmetics or topical skin preparations | |
JP5671211B2 (en) | External preparation for skin containing hydroxycarboxylic acid derivative |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
A621 | Written request for application examination |
Free format text: JAPANESE INTERMEDIATE CODE: A621 Effective date: 20200207 |
|
RD03 | Notification of appointment of power of attorney |
Free format text: JAPANESE INTERMEDIATE CODE: A7423 Effective date: 20200207 |
|
A977 | Report on retrieval |
Free format text: JAPANESE INTERMEDIATE CODE: A971007 Effective date: 20201118 |
|
A131 | Notification of reasons for refusal |
Free format text: JAPANESE INTERMEDIATE CODE: A131 Effective date: 20201215 |
|
A521 | Request for written amendment filed |
Free format text: JAPANESE INTERMEDIATE CODE: A523 Effective date: 20210215 |
|
TRDD | Decision of grant or rejection written | ||
A01 | Written decision to grant a patent or to grant a registration (utility model) |
Free format text: JAPANESE INTERMEDIATE CODE: A01 Effective date: 20210720 |
|
A61 | First payment of annual fees (during grant procedure) |
Free format text: JAPANESE INTERMEDIATE CODE: A61 Effective date: 20210812 |
|
R150 | Certificate of patent or registration of utility model |
Ref document number: 6930847 Country of ref document: JP Free format text: JAPANESE INTERMEDIATE CODE: R150 |
|
R250 | Receipt of annual fees |
Free format text: JAPANESE INTERMEDIATE CODE: R250 |